Home
  >  
Section 12

EurekaMag Full Text Articles Chapter 11,672



References:

Groves, A.M.; Bird, N.; Tabor, I.; Cheow, H.K.; Balan, K.K. 2004: 16-Detector multislice CT-skeletal scintigraphy image co-registration. Nuclear Medicine Communications 25(11): 1151-1155
Zhang, L.J.; Qi, J.; Shen, W. 2006: 16-Slice CT hepatic venography. Abdominal Imaging 31(3): 308-314
Lee, S-Hyong.; Nishino, M.; Mazumdar, T.; Garcia, G.E.; Galfione, M.; Lee, F.L.; Lee, C.L.; Liang, A.; Kim, J.; Feng, L.; Eissa, N.Tony.; Lin, S-Hwa.; Yu-Lee, L-Yuan. 2005: 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway. Cancer Research 65(17): 7984-7992
Gonzalez, C.; Corbacho, A.M.; Eiserich, J.P.; Garcia, C.; Lopez-Barrera, F.; Morales-Tlalpan, V.; Barajas-Espinosa, A.; Diaz-Muñoz, M.; Rubio, R.; Lin, S-Hwa.; Martinez de la Escalera, G.; Clapp, C. 2004: 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 145(12): 5714-5722
Rudolph, T.; Welinder-Olsson, C.; Lind-Brandberg, L.; Stenevi, U. 2004: 16S rDNA PCR analysis of infectious keratitis: a case series. Acta Ophthalmologica Scandinavica 82(4): 463-467
Yang, R-Xian.; Sun, G-Yu.; Zhang, R.; Chen, L-Jun. 2005: 16S rDNA RFLP analysis of endophytic bacteria from Brassica napus. Wei Sheng Wu Xue Bao 45(4): 606-609
Rudi, K.; Skulberg, O.M.; Jakobsen, K.S. 2005: 16S rDNA analyses of the cyanobacterial microbiota through the water-column in a boreal lake with a metalimnic Planktothrix population. Preparative Biochemistry and Biotechnology 35(4): 301-312
Cho, S.-Jeong; Cho, K.-Man; Shin, E.-Chule; Lim, W.-Jin; Hong, S.-Young; Choi, B.-Rock; Kang, J.-Mi; Lee, S.-Mi; Kim, Y.-Hee; Kim, H.; Yun, H.-Dae 2006: 16S rDNA analysis of bacterial diversity in three fractions of cow rumen. Journal of Microbiology and Biotechnology 16(1): 92-101
Yan, L-Ping.; Hong, K.; Hu, S-cai.; Liu, L-hua. 2005: 16S rDNA diversity analysis of 30 Streptomycetes isolates displaying significant cytotoxic activity against B16 cell from near-shore sediments of Hainan Island. Wei Sheng Wu Xue Bao 45(2): 185-190
Zhang-Hai-Tao; Jin-Yan; Yu-Xing-Ju; Zhang-Wei 2005: 16S rDNA-RFLP analysis of actinomycetes associated with marine sponge Hymeniacidon perleve. Weishengwu Xuebao 45(6): 828-831
Romero, J.; Navarrete, P. 2006: 16S rDNA-based analysis of dominant bacterial populations associated with early life stages of coho salmon (Oncorhynchus kisutch). Microbial Ecology 51(4): 422-430
Imhoff, J.F.; Sahling, H.; Sueling, J.; Kath, T. 2003: 16S rDNA-based phylogeny of sulphur-oxidising bacterial endosymbionts in marine bivalves from cold-seep habitats. ine Ecology Progress Series ch 10; 249: 39-51
Purkhold, U.; Wagner, M.; Timmermann, G.; Pommerening-Röser, A.; Koops, H-Peter. 2003: 16S rRNA and amoA-based phylogeny of 12 novel betaproteobacterial ammonia-oxidizing isolates: Extension of the dataset and proposal of a new lineage within the nitrosomonads. International Journal of Systematic and Evolutionary Microbiology 53(Pt 5): 1485-1494
Lehner, A.; Tasara, T.; Stephan, R. 2004: 16S rRNA gene based analysis of Enterobacter sakazakii strains from different sources and development of a PCR assay for identification. Bmc Microbiology 4: 43
Wang, K-Yu.; Guo, Y-Jun.; Sun, S-Han.; Shi, K.; Zhang, S.; Wang, K-Hui.; Yi-Zhang; Chen, Z-Huan. 2006: 16S rRNA gene probe quantitates residual host cell DNA in pharmaceutical-grade plasmid DNA. Vaccine 24(14): 2656-2661
Anukam, K., C.; Osazuwa, E., O.; Ahonkhai, I.; Reid, G. 2005: 16S rRNA gene sequence and phylogenetic tree of lactobacillus species from the vagina of healthy Nigerian women. African Journal of Biotechnology 4(11): 1222-1227
Lindh, J.M.; Terenius, O.; Faye, I. 2005: 16S rRNA gene-based identification of midgut bacteria from field-caught Anopheles gambiae sensu lato and A. funestus mosquitoes reveals new species related to known insect symbionts. Applied and Environmental Microbiology 71(11): 7217-7223
Nonaka, L.; Connell, S.R.; Taylor, D.E. 2005: 16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes. Journal of Bacteriology 187(11): 3708-3712
Nieminen, T.; Pakarinen, J.; Tsitko, I.; Salkinoja-Salonen, M.; Breitenstein, A.; Ali-Vehmas, T.; Neubauer, P. 2006: 16S rRNA targeted sandwich hybridization method for direct quantification of mycobacteria in soils. Journal of Microbiological Methods 67(1): 44-55
Skillman, L.C.; Evans, P.N.; Naylor, G.E.; Morvan, B.; Jarvis, G.N.; Joblin, K.N. 2006: 16S ribosomal DNA-directed PCR primers for ruminal methanogens and identification of methanogens colonising young lambs. Anaerobe 10(5): 277-285
Simpson, J.M.; Stroot, P.G.; Gelman, S.; Beydilli, I.; Dudley, S.; Oerther, D.B. 2006: 16S ribosomal RNA tools identify an unexpected predominance of Paenibacillus-like bacteria in an industrial activated sludge system suffering from poor biosolids separation. Water Environment Research: a Research Publication of the Water Environment Federation 78(8): 864-871
Conrads, G.; Citron, D.M.; Tyrrell, K.L.; Horz, H-Peter.; Goldstein, E.J.C. 2005: 16S-23S rRNA gene internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus Porphyromonas. International Journal of Systematic and Evolutionary Microbiology 55(Pt 2): 607-613
Sunyer, M. 2004: 17 Years of group psychotherapy training: a training experience in evolution. European Journal of Psychiatry 18(Suppl S): 33-43
Ding-Jing-Xin; Yin-Lian-Hua; Jin-Hon-Yan; Liu-Xiao-Xia; Yao-Liang-Qing; Sun-Yun-Yan; Feng-You-Ji 2005: 17 beta estradiol's impact on cell proliferation, invasion and snail expression of ovarian clear cell adenocarcinoma cell line ES-2. Fudan Xuebao 32(5): 522-528
Dykens, J., A.; Wersinger, C.; Sidhu, A. 2005: 17 beta- and 17 alpha-Estradiol are non-competitive inhibitors of dopamine uptake: Implications for Parkinson's disease models and therapeutics. Drug Development Research 66(2): 160-171
Guo, R-Xia.; Wei, L-Hui.; Tu, Z.; Sun, P-Ming.; Wang, J-Liu.; Zhao, D.; Li, X-Ping.; Tang, J-Min. 2006: 17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells. Journal of Steroid Biochemistry and Molecular Biology 99(1): 9-18
Shea, T.B.; Ortiz, D. 2003: 17 beta-estradiol alleviates synergistic oxidative stress resulting from folate deprivation and amyloid-beta treatment. Journal of Alzheimer's Disease: Jad 5(4): 323-327
Peterson, E.; Davis, R.; Orndorff, H. 2000: 17 beta-Estradiol as an indicator of animal waste contamination in mantled karst aquifers. Journal of environmental quality 29(3): 826-834
Chen, Y-Hang.; Lee, M-Jung.; Chang, H-Huei.; Hung, P-Fang.; Kao, Y-Hsi. 2006: 17 beta-estradiol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor, extracellularly regulated kinase, and CCAAT/enhancer binding protein-alpha pathways. Endocrinology 147(9): 4496-4504
Rocha, B.A.; Fleischer, R.; Schaeffer, J.M.; Rohrer, S.P.; Hickey, G.J. 2005: 17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology 179(3): 637-643
Suzuki, T.; Shimizu, T.; Yu, H-Ping.; Hsieh, Y-Ching.; Choudhry, M.A.; Bland, K.I.; Chaudry, I.H. 2006: 17 beta-estradiol administration following trauma-hemorrhage prevents the increase in Kupffer cell cytokine production and MAPK activation predominately via estrogen receptor-alpha. Surgery 140(2): 141-148
Kappert, K.; Caglayan, E.; Huntgeburth, M.; Baeumer, A., T.; Sparwel, J.; Uebel, M.; Rosenkranz, S. 2006: 17 beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level. American Journal of Physiology Heart and Circulatory Physiology 290(2): H538-H546
Kadokami, T.; McTiernan, C.F.; Higuichi, Y.; Frye, C.S.; Kubota, T.; Feldman, A.M. 2005: 17 Beta-estradiol improves survival in male mice with cardiomyopathy induced by cardiac-specific tumor necrosis factor-alpha overexpression. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 25(5): 254-260
Cabilla, J.P.; Díaz, Mía.del.Carmen.; Machiavelli, L.I.; Poliandri, A.H.; Quinteros, F.A.; Lasaga, M.; Duvilanski, B.H. 2006: 17 beta-estradiol modifies nitric oxide-sensitive guanylyl cyclase expression and down-regulates its activity in rat anterior pituitary gland. Endocrinology 147(9): 4311-4318
Ricchi, M.; Bertolotti, M.; Anzivino, C.; Carulli, L.; Canedi, I.; Bormioli, M.Luisa.; Tiozzo, R.; Croce, M.Antonietta.; Lonardo, A.; Carulli, N.; Loria, P. 2006: 17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures. Journal of Gastroenterology and Hepatology 21(5): 894-901
Choi, Y.Cheul.; Lee, J.Hyun.; Hong, K.Whan.; Lee, K.Sup. 2004: 17 Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundamental and Clinical Pharmacology 18(5): 547-557
Zhou-Shou-Hong; Ling-Hong-Yan; Tian-Shao-Wen; Liu-Xian-Qing; Wang-Bing-Xiang; Hu-Bi 2005: 17 beta-estradiol protects against injury of aortic relaxation and contraction in ovariectomized rats with insulin resistance induced by fructose. Shengli Xuebao 57(5): 627-635
Groten, T.; Pierce, A.A.; Huen, A.C.; Schnaper, H.William. 2005: 17 beta-estradiol transiently disrupts adherens junctions in endothelial cells. FASEB Journal 19(10): 1368-1370
Meis, P.J. 2005: 17 hydroxyprogesterone for the prevention of preterm delivery. Obstetrics and Gynecology 105(5 Pt 1): 1128-1135
Burger, A.M.; Fiebig, H-Herbert.; Stinson, S.F.; Sausville, E.A. 2004: 17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models. Anti-Cancer Drugs 15(4): 377-387
Gossett, D.R.; Bradley, M.S.; Jin, X.; Lin, J. 2005: 17-Allyamino-17-demethoxygeldanamycin and 17-NN-dimethyl ethylene diamine-geldanamycin have cytotoxic activity against multiple gynecologic cancer cell types. Gynecologic Oncology 96(2): 381-388
Ogimoto, A.; Hamada, M.; Nakura, J.; Shigematsu, Y.; Hara, Y.; Ohtsuka, T.; Morishima, A.; Kimura, A.; Miki, T.; Hiwada, K. 2004: 17-Year follow-up study of a patient with obstructive hypertrophic cardiomyopathy with a deletion mutation in the cardiac myosin binding protein C gene. Circulation Journal: Official Journal of the Japanese Circulation Society 68(2): 174-177
Braga-Basaria, M.; Hardy, E.; Gottfried, R.; Burman, K.D.; Saji, M.; Ringel, M.D. 2004: 17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels. Journal of Clinical Endocrinology and Metabolism 89(6): 2982-2988
Vasilevskaya, I.A.; O'Dwyer, P.J. 2005: 17-Allylamino-17-demethoxygeldanamycin overcomes TRAIL resistance in colon cancer cell lines. Biochemical Pharmacology 70(4): 580-589
Mukundan, H.; Resta, T.C.; Kanagy, N.L. 2004: 17-beta estradiol independently regulates erythropoietin synthesis and NOS activity during hypoxia. Journal of Cardiovascular Pharmacology 43(2): 312-317
Madsen, S.S.; Skovbølling, Søren.; Nielsen, C.; Korsgaard, B. 2004: 17-beta estradiol and 4-nonylphenol delay smolt development and downstream migration in Atlantic salmon, Salmo salar. Aquatic Toxicology 68(2): 109-120
Mukundan, H.; Kanagy, N.L.; Resta, T.C. 2004: 17-beta estradiol attenuates hypoxic induction of HIF-1alpha and erythropoietin in Hep3B cells. Journal of Cardiovascular Pharmacology 44(1): 93-100
Lu, B.; Jiang, Y.J.; Choy, P.C. 2004: 17-Beta estradiol enhances prostaglandin E2 production in human U937-derived macrophages. Molecular and Cellular Biochemistry 262(1-2): 101-110
Bryant, D.N.; Bosch, M.A.; Rønnekleiv, O.K.; Dorsa, D.M. 2005: 17-Beta estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience 133(1): 343-352
Pérez Martínez, S.; Hermoso, M.; Farina, M.; Ribeiro, M.L.; Rapanelli, M.; Espinosa, M.; Villalón, M.; Franchi, A. 2006: 17-beta-Estradiol upregulates COX-2 in the rat oviduct. Prostaglandins and Other Lipid Mediators 80(3-4): 155-164
Coiret, G.; Matifat, F.; Hague, Fédéric.; Ouadid-Ahidouch, H. 2005: 17-beta-estradiol activates maxi-K channels through a non-genomic pathway in human breast cancer cells. Febs Letters 579(14): 2995-3000
Wang, M.; Tsai, B.M.; Reiger, K.M.; Brown, J.W.; Meldrum, D.R. 2006: 17-beta-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. Journal of Molecular and Cellular Cardiology 40(2): 205-212
Airoldi, F.; Di Mario, C.; Ribichini, F.; Presbitero, P.; Sganzerla, P.; Ferrero, V.; Vassanelli, C.; Briguori, C.; Carlino, M.; Montorfano, M.; Biondi-Zoccai, G.G.L.; Chieffo, A.; Ferrari, A.; Colombo, A. 2005: 17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. American Journal of Cardiology 96(5): 664-667
Malek, D.; Gust, R.; Kleuser, B. 2006: 17-Beta-estradiol inhibits transforming-growth-factor-beta-induced MCF-7 cell migration by Smad3-repression. European Journal of Pharmacology 534(1-3): 39-47
Ronan, B.; Bacque, E.; Barriere, J.C.aude 2004: 17-diazo pristinamycin IIB preparation and synthetic applications. Tetrahedron 60(17): 3819-3824
Banerjee, S.; Das, T.; Chakraborty, S.; Samuel, G.; Korde, A.; Srivastava, S.; Venkatesh, M.; Pillai, M.R.A. 2004: 177Lu-DOTA-lanreotide: a novel tracer as a targeted agent for tumor therapy. Nuclear Medicine and Biology 31(6): 753-759
Faye, M.; Niang, C.D.; Sene, M.; Dieme, E.; Diouf, M.B.; Badiane, C.I. 2004: 178 Lesions des membres inferieurs par explosion de mines terrestres experience de l'hopital principal de Dakar. Medecine et Armees 32(3): 241-248
Tagawa, N.; Muraoka, K.; Okamoto, Y.; Nishida, M.; Katagiri, M.; Kobayashi, Y. 2004: 17alpha-hydroxylase/C17-20 lyase cytochrome P450 mRNA expressions and enzyme activities during the development of arthritis in collagen-induced arthritis mice. Biological and Pharmaceutical Bulletin 27(10): 1663-1665
Mancera, J.Miguel.; Smolenaars, M.; Laiz-Carrión, Rúl.; Martín del Río, Mía.del.Pilar.; Bonga, S.E.Wendelaar.; Flik, G. 2004: 17beta-Estradiol affects osmoregulation in Fundulus heteroclitus. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 139(2): 183-191
Zheng, P.; Si, W.; Bavister, B.D.; Yang, J.; Ding, C.; Ji, W. 2003: 17Beta-estradiol and progesterone improve in-vitro cytoplasmic maturation of oocytes from unstimulated prepubertal and adult rhesus monkeys. Human Reproduction 18(10): 2137-2144
Bake, S.; Sohrabji, F. 2004: 17beta-estradiol differentially regulates blood-brain barrier permeability in young and aging female rats. Endocrinology 145(12): 5471-5475
Hong, H-Jye.; Liu, J-Chi.; Chan, P.; Juan, S-Hui.; Loh, S-Hurng.; Lin, J-Geng.; Cheng, T-Hurng. 2004: 17beta-estradiol downregulates angiotensin-II-induced endothelin-1 gene expression in rat aortic smooth muscle cells. Journal of Biomedical Science 11(1): 27-36
Dean, S., A.; Tan, J.; O'brien, E., R.; Leenen, F., H.H. 2005: 17beta-Estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. American Journal of Physiology Regulatory Integrative and Comparative Physiology 288(3): R759-R766
Fan, T.; Yang, S-Hua.; Johnson, E.; Osteen, B.; Hayes, R.; Day, A.L.; Simpkins, J.W. 2003: 17beta-Estradiol extends ischemic thresholds and exerts neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats. Brain Research 993(1-2): 10-17
Kanda, N.; Watanabe, S. 2003: 17beta-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression. Journal of Investigative Dermatology 121(6): 1500-1509
Dai, Z.; Zhu, H.-Q.; Jiang, D.-J.; Jiang, J.-L.; Deng, H.-W.; Li, Y.-J. 2004: 17beta-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. International Journal of Cardiology 96(2): 223-227
Nuedling, S.; Van Eickels, M.; Allera, A.; Doevendans, P.; Meyer, R.; Vetter, H.; Grohe, C. 2003: 17beta-Estradiol regulates the expression of endothelin receptor type B in the heart. British Journal of Pharmacology 140(1): 195-201
Mankhey, R., W.; Bhatti, F.; Maric, C. 2005: 17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. American Journal of Physiology Renal Physiology 288(2): F399-F405
Chang, N.-Shan; Schultz, L.; Hsu, L.-Jin; Lewis, J.; Su, M.; Sze, C., I. 2005: 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo. Oncogene 24(4): 714-723
Tomaszewska, A.; Guevara, I.; Wilczok, T.; Dembińska-Kieć, A. 2003: 17beta-Estradiol- and lipopolysaccharide-induced changes in nitric oxide, tumor necrosis factor-alpha and vascular endothelial growth factor release from RAW 264.7 macrophages. Gynecologic and Obstetric Investigation 56(3): 152-159
Yen, C.-H.; Lau, Y.-T. 2004: 17beta-Oestradiol enhances aortic endothelium function and smooth muscle contraction in male spontaneously hypertensive rats. Clinical Science 106(5): 541-546
Bengtsson, A.K.; Ryan, E.J.; Giordano, D.; Magaletti, D.M.; Clark, E.A. 2004: 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 104(5): 1404-1410
Bouman, A.; Schipper, M.; Heineman, M.Jan.; Faas, M. 2004: 17beta-estradiol and progesterone do not influence the production of cytokines from lipopolysaccharide-stimulated monocytes in humans. Fertility and Sterility 82(Suppl): 1212-1219
Finlay Moore, O.; Hartel, P.G.; Cabrera, M.L. 2000: 17beta-estradiol and testosterone in soil and runoff from grasslands amended with broiler litter. Journal of Environmental Quality 29(5): 1604-1611
Babiker, F.A.; De Windt, L.J.; van Eickels, M.; Thijssen, V.; Bronsaer, R.J.P.; Grohé, C.; van Bilsen, M.; Doevendans, P.A. 2004: 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway. Circulation 109(2): 269-276
Murashov, A.K.; Pak, E.S.; Hendricks, W.A.; Tatko, L.M. 2004: 17beta-Estradiol enhances neuronal differentiation of mouse embryonic stem cells. Febs Letters 569(1-3): 165-168
Kanda, N.; Watanabe, S. 2004: 17beta-estradiol enhances the production of granulocyte-macrophage colony-stimulating factor in human keratinocytes. Journal of Investigative Dermatology 123(2): 329-337
Nautiyal, J.; Kumar, P.G.; Laloraya, M. 2004: 17Beta-estradiol induces nuclear translocation of CrkL at the window of embryo implantation. Biochemical and Biophysical Research Communications 318(1): 103-112
Adamski, J.; Ma, Z.; Nozell, S.; Benveniste, E.N. 2004: 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter. Molecular Endocrinology 18(8): 1963-1974
Pezzella, A.; Manini, P.; Di Donato, P.; Boni, R.; Napolitano, A.; Palumbo, A.; d'Ischia, M. 2004: 17beta-Estradiol nitration by peroxidase/H2O2/NO2-: a chemical assessment. Bioorganic and Medicinal Chemistry 12(11): 2927-2936
Plahta, W.C.; Clark, D.L.; Colbourne, F. 2004: 17beta-estradiol pretreatment reduces CA1 sector cell death and the spontaneous hyperthermia that follows forebrain ischemia in the gerbil. Neuroscience 129(1): 187-193
Sakazaki, H.; Ido, R.; Ueno, H.; Nakamuro, K. 2005: 17beta-estradiol primes elicitation of inducible nitric oxide synthase expression by lipopolysaccharide and interferon-gamma in mouse macrophage cell line J774.1. Journal of Health Science 51(1): 62-69
Stroppolo, A.; Tian, C.; Guinea, B.; Olm, V.; Sheffield, R.; Sommer, J.; Ehrlich, M.E. 2004: 17beta-Estradiol promotes striatal medium size spiny neuronal maturation in vitro. Neuroendocrinology 79(5): 259-267
Takao, T.; Flint, N.; Lee, L.; Ying, X.; Merrill, J.; Chandross, K.J. 2004: 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. Journal of Neurochemistry 89(3): 660-673
Patten, R.D.; Pourati, I.; Aronovitz, M.J.; Baur, J.; Celestin, F.; Chen, X.; Michael, A.; Haq, S.; Nuedling, S.; Grohe, C.; Force, T.; Mendelsohn, M.E.; Karas, R.H. 2004: 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circulation Research 95(7): 692-699
Yang, L.; Liang, J.; Yao, G.; Chen, P.; Hou, Y. 2005: 17beta-estradiol regulates the numbers, endocytosis, stimulative capacity and IL-10 secretion of mouse spleen dendritic cells. Toxicology Letters (Shannon) 155(2): 239-246
Karanth, S.; Yu, W.H.; Mastronardi, C.M.; McCann, S.M. 2004: 17beta-estradiol stimulates ascorbic acid and LHRH release from the medial basal hypothalamus in adult male rats. Experimental Biology and Medicine 229(9): 926-934
Kanda, N.; Watanabe, S. 2004: 17beta-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression. Journal of Investigative Dermatology 123(2): 319-328
Lesmeister, M.J.; Jorgenson, R.L.; Young, S.L.; Misfeldt, M.L. 2005: 17Beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells. Reproductive Biology and Endocrinology: Rb&e 3: 74
Oduwole, O.O.; Li, Y.; Isomaa, V.V.; Mäntyniemi, A.; Pulkka, A.E.; Soini, Y.; Vihko, P.T. 2004: 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer. Cancer Research 64(20): 7604-7609
Motojima, K. 2004: 17beta-hydroxysteroid dehydrogenase type 11 is a major peroxisome proliferator-activated receptor alpha-regulated gene in mouse intestine. European Journal of Biochemistry 271(20): 4141-4146
Oduwole, O.O.; Mäkinen, M.J.; Isomaa, V.V.; Pulkka, A.; Jernvall, P.; Karttunen, T.J.; Vihko, P.T. 2003: 17Beta-hydroxysteroid dehydrogenase type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancer. Journal of Steroid Biochemistry and Molecular Biology 87(2-3): 133-140
Lunga, P.; Herbert, J. 2004: 17Beta-oestradiol modulates glucocorticoid, neural and behavioural adaptations to repeated restraint stress in female rats. Journal of Neuroendocrinology 16(9): 776-785
Marques, W.; Freitas, M.R.; Nascimento, O.J.M.; Oliveira, A.B.; Calia, L.; Melo, A.; Lucena, R.; Rocha, V.; Barreira, A.A. 2005: 17p duplicated Charcot-Marie-Tooth 1A: characteristics of a new population. Journal of Neurology 252(8): 972-979
Wilhelmsen, K.C.; Forman, M.S.; Rosen, H.J.; Alving, L.I.; Goldman, J.; Feiger, J.; Lee, J.V.; Segall, S.K.; Kramer, J.H.; Lomen-Hoerth, C.; Rankin, K.P.; Johnson, J.; Feiler, H.S.; Weiner, M.W.; Lee, V.M-Y.; Trojanowski, J.Q.; Miller, B.L. 2004: 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Archives of Neurology 61(3): 398-406
Bourdeau, I.; Matyakhina, L.; Stergiopoulos, S.G.; Sandrini, F.; Boikos, S.; Stratakis, C.A. 2006: 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 91(9): 3626-3632
Steinbronn, R. 2005: 18 Monate GKV-Modernisierungsgesetz - Bewertung und Ausblick: die Sicht der Krankenkassen. Zeitschrift fuer Kardiologie 94(Suppl 4): 15-18
van Ginderdeuren, R.; van Limbergen, E.; Spileers, W. 2005: 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma. British Journal of Ophthalmology 89(10): 1306-1310
Glick, S.D.; Ramirez, R.L.; Livi, J.M.; Maisonneuve, I.M. 2006: 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats. European Journal of Pharmacology 537(1-3): 94-98
Sukhotina, I.; Streckert, J.R.; Bitz, A.K.; Hansen, V.W.; Lerchl, A. 2006: 1800 MHz electromagnetic field effects on melatonin release from isolated pineal glands. Journal of Pineal Research uary; 40(1): 86-91
Capri, M.; Scarcella, E.; Bianchi, E.; Fumelli, C.; Mesirca, P.; Agostini, C.; Remondini, D.; Schuderer, J.; Kuster, N.; Franceschi, C.; Bersani, F. 2004: 1800 MHz radiofrequency (mobile phones, different Global System for Mobile communication modulations) does not affect apoptosis and heat shock protein 70 level in peripheral blood mononuclear cells from young and old donors. International Journal of Radiation Biology 80(6): 389-397
Nivet, C. 2006: 1848: Gregor Mendel,le moine qui voulait etre citoyen. M S (Medecine Sciences) 22(4): 430-433
Bao, A.; Goins, B.; Klipper, R.; Negrete, G.; Phillips, W.T. 2003: 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(12): 1992-1999
Lambert, B.; Bacher, K.; Defreyne, L.; Gemmel, F.; Van Vlierberghe, H.; Jeong, J.Min.; Dierckx, R.A.; Van de Wiele, C.; Thierens, H.; De Vos, F. 2005: 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 46(1): 60-66
Garin, E.; Denizot, B.; Noiret, N.; Lepareur, N.; Roux, J.; Moreau, M.; Herry, J-Yves.; Bourguet, P.; Benoit, J-Pierre.; Lejeune, J-Jacques. 2004: 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma. Nuclear Medicine Communications 25(10): 1007-1013
Iznaga-Escobar, N.; Ramirez, I.L.; Izquierdo, J.C.; Suárez, L.; Morales, D.; Pérez-Rodríguez, R. 2003: 188Re-labeled anti-epidermal growth factor receptor humanized monoclonal antibody h-R3: labeling conditions, in vitro and in vivo stability. Methods and Findings in Experimental and Clinical Pharmacology 25(9): 703-711
Bauer, A.; Langen, K-Josef.; Bidmon, H.; Holschbach, M.H.; Weber, S.; Olsson, R.A.; Coenen, H.H.; Zilles, K. 2005: 18F-CPFPX PET identifies changes in cerebral A1 adenosine receptor density caused by glioma invasion. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 46(3): 450-454
Jeong, Y.; Cho, S.Soo.; Park, J.Mi.; Kang, S.J.; Lee, J.Sung.; Kang, E.; Na, D.L.; Kim, S.Eun. 2005: 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 46(2): 233-239
Brogsitter, C.; Grüning, T.; Weise, R.; Wielepp, P.; Lindner, O.; Körfer, R.; Burchert, W. 2005: 18F-FDG PET for detecting myocardial viability: validation of 3D data acquisition. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 46(1): 19-24
Kumar, R.; Xiu, Y.; Potenta, S.; Mavi, A.; Zhuang, H.; Yu, J.Q.; Dhurairaj, T.; Dadparvar, S.; Alavi, A. 2004: 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(11): 1796-1803
Kumar, R.; Xiu, Y.; Yu, J.Q.; Takalkar, A.; El-Haddad, G.; Potenta, S.; Kung, J.; Zhuang, H.; Alavi, A. 2004: 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(12): 2058-2062
Choi, J.Young.; Jang, H-Ju.; Shim, Y.Mog.; Kim, K.; Lee, K.Soo.; Lee, K-Han.; Choi, Y.; Choe, Y.Seong.; Kim, B-Tae. 2004: 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(11): 1843-1850
Sugiyama, M.; Sakahara, H.; Torizuka, T.; Kanno, T.; Nakamura, F.; Futatsubashi, M.; Nakamura, S. 2004: 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. Journal of Gastroenterology 39(10): 961-968
Spence, A.M.; Muzi, M.; Mankoff, D.A.; O'Sullivan, S.Finbarr.; Link, J.M.; Lewellen, T.K.; Lewellen, B.; Pham, P.; Minoshima, S.; Swanson, K.; Krohn, K.A. 2004: 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(10): 1653-1659
Gotthardt, M.; Battmann, A.; Höffken, H.; Schurrat, T.; Pollum, H.; Beuter, D.; Gratz, S.; Béhé, M.; Bauhofer, A.; Klose, K.J.; Behr, T.M. 2004: 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature. Nuclear Medicine Communications 25(5): 439-443
Ogawa, M.; Ishino, S.; Mukai, T.; Asano, D.; Teramoto, N.; Watabe, H.; Kudomi, N.; Shiomi, M.; Magata, Y.; Iida, H.; Saji, H. 2004: (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(7): 1245-1250
Strauss, L.G.; Dimitrakopoulou-Strauss, A.; Koczan, D.; Bernd, L.; Haberkorn, U.; Ewerbeck, V.; Thiesen, H-Jürgen. 2004: 18F-FDG kinetics and gene expression in giant cell tumors. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(9): 1528-1535
Tseng, J.; Dunnwald, L.K.; Schubert, E.K.; Link, J.M.; Minoshima, S.; Muzi, M.; Mankoff, D.A. 2004: 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(11): 1829-1837
Calvo, F.A.; Domper, M.; Matute, Rúl.; Martínez-Lázaro, Rúl.; Arranz, Jé.A.; Desco, M.; Alvarez, E.; Carreras, Jé.Luis. 2004: 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. International Journal of Radiation Oncology Biology Physics 58(2): 528-535
Higashi, K.; Ito, K.; Hiramatsu, Y.; Ishikawa, T.; Sakuma, T.; Matsunari, I.; Kuga, G.; Miura, K.; Higuchi, T.; Tonami, H.; Yamamoto, I. 2005: 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 46(2): 267-273
Yen, T-Chen.; See, L-Chu.; Lai, C-Huey.; Yah-Huei, C.Wu.; Ng, K-Kwan.; Ma, S-Ya.; Lin, W-Jyh.; Chen, J-Tzong.; Chen, W-Jie.; Lai, C-Ru.; Hsueh, S. 2004: 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(1): 22-29
Cobben, D.C.P.; van der Laan, B.F.A.M.; Maas, B.; Vaalburg, W.; Suurmeijer, A.J.H.; Hoekstra, H.J.; Jager, P.L.; Elsinga, P.H. 2004: 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(2): 226-231
Hoffmann, M.; Chott, A.; Püspök, A.; Jäger, U.; Kletter, K.; Raderer, M. 2004: 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum. Annals of Hematology 83(5): 276-278
Tenenbaum, F.; Groussin, L.; Foehrenbach, Hé.; Tissier, Fédérique.; Gouya, Hé.; Bertherat, Jérôme.; Dousset, B.; Legmann, P.; Richard, B.; Bertagna, X. 2004: 18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients. European Journal of Endocrinology 150(6): 789-792
Johns Putra, L.; Putra, L.Johns.; Lawrentschuk, N.; Ballok, Z.; Hannah, A.; Poon, A.; Tauro, A.; Davis, I.D.; Hicks, R.J.; Bolton, D.M.; Scott, A.M. 2004: 18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy. Urology 64(6): 1202-1207
Hong, S.P.; Hahn, J.S.; Lee, J.D.; Bae, S.W.; Youn, M.J. 2003: 18F-fluorodeoxyglucose-positron emission tomography in the staging of malignant lymphoma compared with CT and 67Ga scan. Yonsei Medical Journal 44(5): 779-786
Glaser, M.; Karlsen, H.; Solbakken, M.; Arukwe, J.; Brady, F.; Luthra, S.K.; Cuthbertson, A. 2004: 18F-fluorothiols: A new approach to label peptides chemoselectively as potential tracers for positron emission tomography. Bioconjugate Chemistry 15(6): 1447-1453
Chen, X.; Park, R.; Shahinian, A.H.; Tohme, M.; Khankaldyyan, V.; Bozorgzadeh, M.H.; Bading, J.R.; Moats, R.; Laug, W.E.; Conti, P.S. 2004: 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nuclear Medicine and Biology 31(2): 179-189
Zijlstra, Jée.M.; Hoekstra, O.S.; Raijmakers, P.G.H.M.; Comans, E.F.I.; van der Hoeven, J.J.M.; Teule, G.J.J.; Jonkhoff, A.Roelof.; v Tinteren, H.; Lammertsma, A.A.; Huijgens, P.C. 2003: 18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma. British Journal of Haematology 123(3): 454-462
Korinthenberg, R.; Bauer-Scheid, C.; Burkart, P.; Martens-Le Bouar, H.; Kassubek, J.; Juengling, F.D. 2004: 18FDG-PET in epilepsies of infantile onset with pharmacoresistant generalised tonic-clonic seizures. Epilepsy Research 60(1): 53-61
Sakai, J.; Kojima, S.; Yanagi, K.; Kanaoka, M. 2005: 18O-labeling quantitative proteomics using an ion trap mass spectrometer. Proteomics 5(1): 16-23
Deng-Wang-Qiu; Song-Bin; Lin-Qun-Ying; Guan-Ze-Ting; Li-Tai-Hui 2004: 18S rDNA partial sequences of Dictyophora duplicata & Phallus impudicus and their phylogenetic implications. Journal of Fungal Research 2(1): 35-39
Erseus, C.; Kallersjo, M. 2004: 18S rDNA phylogeny of Clitellata (Annelida). Zoologica Scripta 33(2): 187-196
Kudryavtsev, A.; Bernhard, D.; Schlegel, M.; Chao, E.E.Y.; Cavalier-Smith, T. 2005: 18S ribosomal RNA gene sequences of Cochliopodium (Himatismenida) and the phylogeny of Amoebozoa. Protist 156(2): 215-224
Linnankivi, T.; Tienari, P.; Somer, M.; Kähkönen, M.; Lönnqvist, T.; Valanne, L.; Pihko, H. 2006: 18q deletions: clinical, molecular, and brain MRI findings of 14 individuals. American Journal of Medical Genetics. Part A 140(4): 331-339
Tai, Y-Chin.; Tan, J-Ai.Mary.Anne.; Peh, S-Cheng. 2004: 18q21 Rearrangement and trisomy 3 in extranodal B-cell lymphomas: a study using a fluorescent in situ hybridisation technique. Virchows Archiv: An International Journal of Pathology 445(5): 506-514
Anonymous 2004: 18th European Platelet Meeting, Giessen, Germany, October 10-11, 2003. Platelets 15(3): 188-197
Lamers, C.B.H.W. 2004: 18th Highlights of Gastroenterology and Hepatology. Scandinavian Journal of Gastroenterology 39(Suppl 241): 1-3
Anonymous 2004: 18th Journees Franco-Belges de Pharmacochimie, Luxembourg, Luxembourg, June 3-4, 2004. Fundamental and Clinical Pharmacology 18(5): 593-599
Anonymous 2003: 18th Venezuelan Phytopathology Congress, Maracay, Venezuela, November 11-14, 2003. Fitopatologia Venezolana 16(2): 42-79
Kumagai, T.; Shih, L-Yung.; Hughes, S.V.; Desmond, J.C.; O'Kelly, J.; Hewison, M.; Koeffler, H.Phillip. 2005: 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia. Cancer Research 65(6): 2488-2497
Molnár, Ián.; Kute, T.; Willingham, M.C.; Schwartz, G.G. 2004: 19-Nor-1alpha,25-dihydroxyvitamin D2 (paricalcitol) exerts anticancer activity against HL-60 cells in vitro at clinically achievable concentrations. Journal of Steroid Biochemistry and Molecular Biology 89-90(1-5): 539-543
Brännvall, K.; Bogdanovic, N.; Korhonen, L.; Lindholm, D. 2005: 19-Nortestosterone influences neural stem cell proliferation and neurogenesis in the rat brain. European Journal of Neuroscience 21(4): 871-878
Reid, A.H.; Janczewski, T.A.; Lourens, R.M.; Elliot, A.J.; Daniels, R.S.; Berry, C.L.; Oxford, J.S.; Taubenberger, J.K. 2003: 1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. Emerging Infectious Diseases 9(10): 1249-1253
Taubenberger, J.K.; Morens, D.M. 2006: 1918 Influenza: the mother of all pandemics. Emerging Infectious Diseases 12(1): 15-22
Chuck, R.S.; Shehada, R.E.N.; Taban, M.; Tungsiripat, T.; Sweet, P.M.; Mansour, H.N.; Grundfest, W.S.; McDonnell, P.J. 2004: 193-nm excimer laser-induced fluorescence detection of fluoroquinolones in rabbit corneas. Archives of Ophthalmology 122(11): 1693-1699
Spence, J.R.; Bobowski, B.R. 2003: 1994-1997 water bird surveys of Lake Powell, a large oligotrophic reservoir on the Colorado River, Utah and Arizona. Western Birds 34(3): 133-148
Pierce, L.J.; Moughan, J.; White, J.; Winchester, D.P.; Owen, J.; Wilson, J.Frank. 2005: 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer. International Journal of Radiation Oncology Biology Physics 62(1): 183-192
Chu, K.C.; Chu, K.T. 2005: 1999-2001 Cancer mortality rates for Asian and Pacific Islander ethnic groups with comparisons to their 1988-1992 rates. Cancer 104(12 Suppl): 2989-2998
Kitamura, K.; Kume, M.; Yamamoto, M.; Takegami, S.; Kitade, T. 2004: 19F NMR spectroscopic study on the binding of triflupromazine to bovine and human serum albumins. Journal of Pharmaceutical and Biomedical Analysis 36(2): 411-414
Kamm, Y.J.L.; Heerschap, A.; van den Bergh, E.J.; Wagener, D.J.Theo. 2004: 19F-magnetic resonance spectroscopy in patients with liver metastases of colorectal cancer treated with 5-fluorouracil. Anti-Cancer Drugs 15(3): 229-233
Yu, Y.; Alwine, J.C. 2006: 19S late mRNAs of simian virus 40 have an internal ribosome entry site upstream of the virion structural protein 3 coding sequence. Journal of Virology 80(13): 6553-6558
Anonymous 2003: 19th Argentine Meeting of Vertebrate Paleontology, Buenos Aires, Capital Federal, Argentina, May 12-16, 2003. Ameghiniana 40(4 Suppl): 50R-76R, 30
Gutierrez-De, G.-Omaira; Martinez, M.; Sanabria, L.; De-Pinto, G.-Leon; Igartuburu, J.M.nuel 2005: 1D- and 2D-NMR spectroscopy studies of the polysaccharide gum from Spondias purpurea var. lutea. Food Hydrocolloids 19(1): 37-43
Kaplan, P.A.; Frazier, S.R.; Loy, T.S.; Diaz-Arias, A.A.; Bradley, K.; Bickel, J.T. 2005: 1D5 and 6F11: An immunohistochemical comparison of two monoclonal antibodies for the evaluation of estrogen receptor status in primary breast carcinoma. American Journal of Clinical Pathology 123(2): 276-280
Kantarci, K.; Petersen, R.C.; Boeve, B.F.; Knopman, D.S.; Tang-Wai, D.F.; O'Brien, P.C.; Weigand, S.D.; Edland, S.D.; Smith, G.E.; Ivnik, R.J.; Ferman, T.J.; Tangalos, E.G.; Jack, C.R. 2004: 1H MR spectroscopy in common dementias. Neurology 63(8): 1393-1398
Ross, A.J.; Sachdev, P.S.; Wen, W.; Valenzuela, M.J.; Brodaty, H. 2005: 1H MRS in stroke patients with and without cognitive impairment. Neurobiology of Aging 26(6): 873-882
Del Signore, A.G.; McGregor, M.; Cho, B.P. 2005: 1H NMR analysis of GHB and GBL: further findings on the interconversion and a preliminary report on the analysis of GHB in serum and urine. Journal of Forensic Sciences 50(1): 81-86
Veselkov, A.N.; Evstigneev, M.P.; Rozvadovskaia, A.O.; Mukhina, I.V.; Rybakova, K.A. 2005: 1H NMR analysis of the complex formation of aromatic molecules of antibiotic and vitamin in aqueous solution: heteroassociation of actinomycin D and flavin mononucleotide. Biofizika 50(1): 20-27
Brescia, M.A.; Mazzilli, V.; Sgaramella, A.; Ghelli, S.; Fanizzi, F.P.; Sacco, A. 2004: 1H NMR characterization of milk lipids: A comparison between cow and buffalo milk. Journal of the American Oil Chemists' Society 81(5): 431-436
Liu, Y.; Zhang, X.; Yoshida, T.; La Mar, G.N. 2004: 1H NMR characterization of the solution active site structure of substrate-bound, cyanide-inhibited heme oxygenase from Neisseria meningitidis: comparison to crystal structures. Biochemistry 43(31): 10112-10126
Terpstra, M.; Gruetter, R. 2004: 1H NMR detection of vitamin C in human brain in vivo. Magnetic Resonance in Medicine 51(2): 225-229
Li, Y.; Syvitski, R.T.; Auclair, K.; de Montellano, P.R.Ortiz.; La Mar, G.N. 2003: 1H NMR investigation of the solution structure of substrate-free human heme oxygenase: comparison to the cyanide-inhibited, substrate-bound complex. Journal of Biological Chemistry 279(11): 10195-10205
Li, Y.; Li, Q.; Sun, M.; Song, G.; Jiang, S.; Zhu, D. 2004: 1H NMR relaxation investigation of acetylcholinesterase inhibitors from huperzine A and derivative. Bioorganic and Medicinal Chemistry Letters 14(6): 1585-1588
Ishizuka, Y.; Nemoto, T.; Kanazawa, K.; Nakanishi, H. 2004: 1H NMR spectra of branched-chain cyclomaltohexaoses (alpha-cyclodextrins). Carbohydrate Research 339(4): 777-785
D.C., M.E.; Bianchetti, C.; Chiellini, F. 2003: 1H NMR studies of alginate interactions with amino acids. Journal of Bioactive and Compatible Polymers 18(4): 283-296
Cao, C.; Zhang, Q.; Wang, Z-Qiang.; Wang, Y-Feng.; Wang, Y-Hua.; Wu, H.; Huang, Z-Xian. 2003: 1H NMR studies of the effect of mutation at Valine45 on heme microenvironment of cytochrome b5. Biochimie 85(10): 1007-1016
Dupuy, N.; Barbry, D.; Bria, M.; Marquis, S.; Vrielynck, L.; Kister, J. 2005: 1H NMR study of inclusion compounds of phenylurea derivatives in beta-cyclodextrin. Spectrochimica Acta. Part A Molecular and Biomolecular Spectroscopy 61(6): 1051-1057
Diaz, M.F.; Hernandez, F.; Ledea, O.; Sazatornil, J.A.G.vin; Moleiro, J. 2003: 1H NMR study of methyl linoleate ozonation. Ozone Science and Engineering 25(2): 121-126
Hetherington, H.P.; Kim, J.H.; Pan, J.W.; Spencer, D.D. 2004: 1H and 31P spectroscopic imaging of epilepsy: spectroscopic and histologic correlations. Epilepsia 45(Suppl): 17-23
Lucas, L.H.; Cerny, M.A.; Koen, Y.M.; Hanzlik, R.P.; Larive, C.K. 2004: 1H high-resolution magic-angle spinning (HR-MAS) NMR analysis of ligand density on resins using a resin internal standard. Analytical and Bioanalytical Chemistry 380(4): 627-631
Calucci, L.; Forte, C.; Galleschi, L. 2004: 1H magnetization transfer in hydrated gluten and flour: effects of wheat aging. Biomacromolecules 5(5): 1824-1831
Libralesso, E.; Nerinovski, K.; Parigi, G.; Turano, P. 2005: 1H nuclear magnetic relaxation dispersion of Cu,Zn superoxide dismutase in the native and guanidinium-induced unfolded forms. Biochemical and Biophysical Research Communications 328(2): 633-639
Talebpour, Z.; Haghgoo, S.; Shamsipur, M. 2004: 1H nuclear magnetic resonance spectroscopy analysis for simultaneous determination of levodopa, carbidopa and methyldopa in human serum and pharmaceutical formulations. Analytica Chimica Acta 506(1): 97-104
Kato, Y.; Akai, A.; Suzuki, R.; Hosokawa, H.; Ninomiya, H.; Masaki, T.; Nagata, K.; Tanokura, M. 2004: 1H, 13C and 15N assignments of the tandem WW domains of human MAGI-1/BAP-1. Journal of Biomolecular NMR 29(4): 539-540
Mohanty, S.; Zubkov, S.; Campos-Olivas, R.ón. 2003: 1H, 13C and 15N backbone assignments of the pheromone binding protein from the silk moth Antheraea polyphemus (ApolPBP). Journal of Biomolecular NMR 27(4): 393-394
Ou, L.; Zhang, Q.; Ma, J.; Wu, W.; Wang, Z.; Zhang, F.; Ma, D.; Wu, H. 2004: 1H, 13C and 15N backbone resonance assignments of matrilysin (MMP7) complexed with a sulfonamide hydroxamate-type inhibitor. Journal of Biomolecular NMR 29(4): 537-538
Trivelli, X.; Krimm, I.; Verdoucq, L.; Chartier, Y.; Tsan, P.; Meyer, Y.; Lancelin, J.-M. 2004: 1H, 13C and 15N backbone resonance assignments of the dimeric yeast peroxiredoxin YLR109w. Journal of Biomolecular NMR 28(1): 95-96
Impagliazzo, A.; Ubbink, M. 2004: 1H, 13C and 15N resonance assignment of Cu(I)-pseudoazurin from Alcaligenes faecalis S-6. Journal of Biomolecular NMR 29(4): 541-542
Thureau, A.él.; Olry, A.; Coudevylle, N.; Azza, S.ïd.; Boschi-Muller, S.; Branlant, G.; Cung, M.-T. 2004: 1H, 13C and 15N resonance assignment of the methionine sulfoxide reductase B from Neisseria meningitidis. Journal of Biomolecular NMR 30(2): 223-224
Zhou, H.; Gallina, M.; Mao, H.; Nietlispach, D.; Betz, S.F.; Fetrow, J.S.; Domaille, P.J. 2003: 1H, 13C and 15N resonance assignments and secondary structure of the human protein tyrosine phosphatase, PRL-2. Journal of Biomolecular NMR 27(4): 397-398
Koch, A.W.; Farooq, A.; Zeng, L.; Colman, D.R.; Zhou, M.-M. 2004: 1H, 13C and 15N resonance assignments for the N-cadherin prodomain. Journal of Biomolecular NMR 28(1): 87-88
Wei, Y.; Fela, D.; Kim, S.; Hecht, M.; Baum, J. 2003: 1H, 13C and 15N resonance assignments of S-824, a de novo four-helix bundle from a designed combinatorial library. Journal of Biomolecular NMR 27(4): 395-396
Gaiser, O.J.; Oschkinat, H.; Heinemann, U.; Ball, L.J. 2004: 1H, 13C and 15N resonance assignments of the C-terminal BRCT domain from human BRCA1. Journal of Biomolecular NMR 30(2): 221-222
Kowalski, K.; Merkel, A.L.; Booker, G.W. 2004: 1H, 13C and 15N resonance assignments of the third spectrin repeat of alpha-actinin-4. Journal of Biomolecular NMR 29(4): 533-534
Horstmann, M.; Kamphausen, T.; Schweimer, K.; Steinert, M.; Hacker, Jörg.; Haase, A.; Rösch, P.; Schweimer, G.; Faber, C. 2005: 1H, 13C, 15N backbone and sidechain resonance assignment of Mip(77-213) the PPIase domain of the Legionella pneumophila Mip protein. Journal of biomolecular NMR 31(1): 77-78
Ito, M.; Nagata, K.; Yumoto, F.; Yamagoe, S.; Suzuki, K.; Adachi, K.; Tanokura, M. 2004: 1H, 13C, 15N resonance assignments of the cytokine LECT2. Journal of Biomolecular NMR 29(4): 543-544
Black, G.; Wenzler, M.; Wang, X.; Krych-Goldberg, M.; Atkinson, J.P.; Barlow, P.N. 2004: 1H, 15N and 13C resonance assignments of complement control protein module pair 2-3 from the C4b-binding site of complement receptor type 1. Journal of Biomolecular NMR 30(2): 227-228
Li, X.; Peterkofsky, A.; Wang, G. 2003: 1H, 15N, and 13C chemical shift assignments of the Escherichia coli nitrogen regulatory phosphocarrier IIA(Ntr). Journal of Biomolecular NMR 27(4): 401-402
Ulrich, D.L.; Thompson, R.; Bassler, B.; Cavanagh, J.; Loria, J.P. 2004: 1H, 15N, and 13C chemical shift assignments of the Vibrio harveyi histidine phosphotransferase protein LuxU. Journal of Biomolecular NMR 29(4): 551-552
Lin, T.-H.; Huang, J.-W.; Huang, H.-b.; Chen, Y.-c.; Liu, C.-Y.; Lo, C.-j.; Tang, T.C.; Chyan, C.-L. 2004: 1H, 15N, and 13C resonance assignments of calmodulin complexed with the calmodulin-binding domain of calcineurin. Journal of Biomolecular NMR 29(4): 531-532
Hammen, T.; Stefan, H.; Pauli, E.; Schäfer, I.; Huk, W.; Tomandl, B. 2003: 1H-MR spectroscopy: A promising method in distinguishing subgroups in temporal lobe epilepsy?. Journal of the Neurological Sciences 215(1-2): 21-25
Hammen, T.; Stefan, H. 2004: 1H-MR-spektroskopie Methoden und anwendungen in der diagnostik und beurteilung operativer und konservativer therapiestrategien bei epilepsien. Nervenarzt 75(10): 970-983
Jones, R.S.; Waldman, A.D. 2004: 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. Neurological Research 26(5): 488-495
Yamamoto, Y.; Koshikawa, K.; Terui, N.; Mita, H.; Matsuoka, A.; Shikama, K. 2003: 1H-NMR study of dynamics and thermodynamics of Cl- binding to ferric hemoglobin of a midge larva (Tokunagayusurika akamusi). Biochimica et Biophysica Acta 1652(2): 136-143
Serkova, N.; Fuller, T.Florian.; Klawitter, J.; Freise, C.E.; Niemann, C.U. 2005: H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney International 67(3): 1142-1151
Metcalfe, E.E.; Zamoon, J.; Thomas, D.D.; Veglia, G. 2004: (1)H/(15)N heteronuclear NMR spectroscopy shows four dynamic domains for phospholamban reconstituted in dodecylphosphocholine micelles. Biophysical Journal 87(2): 1205-1214
Raz, P.; Lohmann, C.H.; Turner, J.; Wang, L.; Poythress, N.; Blanchard, C.; Boyan, B.D.; Schwartz, Z. 2004: 1alpha,25(OH)2D3 regulation of integrin expression is substrate dependent. Journal of Biomedical Materials Research. Part A 71(2): 217-225
Gentili, C.; Morelli, S.; de Boland, A.Russo. 2004: 1alpha,25(OH)2D3 and parathyroid hormone (PTH) signaling in rat intestinal cells: activation of cytosolic PLA2. Journal of Steroid Biochemistry and Molecular Biology 89-90(1-5): 297-301
Riis, J.L.; Johansen, C.; Gesser, B.; Møller, K.; Larsen, C.G.; Kragballe, K.; Iversen, L. 2004: 1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in Ikappa Balpha expression. Archives of Dermatological Research 296(5): 195-202
Clark, C.S.; Konyer, J.E.; Meckling, K.A. 2004: 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression. Experimental Cell Research 294(1): 301-311
Van Der Stede, Y.; Verfaillie, T.; Cox, E.; Verdonck, F.; Goddeeris, B.M. 2004: 1alpha,25-dihydroxyvitamin D3 increases IgA serum antibody responses and IgA antibody-secreting cell numbers in the Peyer's patches of pigs after intramuscular immunization. Clinical and Experimental Immunology 135(3): 380-390
Levine, M.J.; Teegarden, D. 2004: 1alpha,25-dihydroxycholecalciferol increases the expression of vascular endothelial growth factor in C3H10T1/2 mouse embryo fibroblasts. Journal of Nutrition 134(9): 2244-2250
Murthy, S.; Weigel, N.L. 2004: 1alpha,25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway. Prostate 59(3): 282-291
van Halteren, A.G.S.; Tysma, O.M.; van Etten, E.; Mathieu, C.; Roep, B.O. 2004: 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. Journal of Autoimmunity 23(3): 233-239
Snow, J.L.; Persia, M.E.; Biggs, P.E.; Baker, D.H.; Parsons, C.M. 2003: 1alpha-hydroxycholecalciferol has little effect on phytate phosphorus utilization in laying hen diets. Poultry Science 82(11): 1792-1795
Esteban, L.; Vidal, M.; Dusso, A. 2004: 1alpha-Hydroxylase transactivation by gamma-interferon in murine macrophages requires enhanced C/EBPbeta expression and activation. Journal of Steroid Biochemistry and Molecular Biology: 89-90(1-5): 131-137
Gouiric, S.C.; Feresin, G.E.; Tapia, A.A.; Rossomando, P.C.; Schmeda Hirschmann, G.; Bustos, D.A. 2004: 1beta,7beta-Dihydroxydehydroabietic acid, a new biotransformation product of dehydroabietic acid by Aspergillus niger. World Journal of Microbiology and Biotechnology 20(3): 281-284
Iriguchi, Yousuke; Hosoi, Tozo; Yamamura, Akihiko; Et-Al 2000: 1p type of advanced squamous cell carcinoma located in the cardia of the stomach, developing from the esophageal mucosa of the esophagogastric junctional region, report of a case. Stomach and Intestine 35(9): 1203-1209
Chee, Y.C. 2004: 1st college of physicians lecture: the role of internal medicine as a specialty in the era of subspecialisation. Annals of the Academy of Medicine Singapore 33(6): 725-732
Boyle, N., A.; Fagan, P.; Brooks, J., L.; Prhavc, M.; Lambert, J.; Cook, P.D.n 2005: 2 ',3 '-dideoxynucleoside 5 '-beta,gamma-(difluoromethylene) triphosphates with alpha-P-thio or alpha-P-seleno modifications: Synthesis and their inhibition of HIV-1 reverse transcriptase. Nucleosides Nucleotides and Nucleic Acids 24(10-12): 1651-1664
Zhao, X. 2005: 2 '-MeO-RNA containing oligodeoxyribonucleotide primers can prevent template-independent base extension on microarrays. Nucleosides Nucleotides and Nucleic Acids 24(10-12): 1843-1852
Dambruoso, P.; Bassarello, C.; Bifulco, G.; Appendino, G.; Battaglia, A.; Guerrini, A.; Fontana, G.; Gomez-Paloma, L. 2005: 2 '-Methyl taxanes: Synthesis and NMR configurational assignment. Tetrahedron Letters 46(19): 3411-3415
Rezanka, L.J.; Kenny, J.J.; Longo, D.L. 2005: 2 BCR or NOT 2 BCR - receptor dilution: a unique mechanism for preventing the development of holes in the protective B cell repertoire. Immunobiology 210(10): 769-774
Singal, P.; Gupta, R.; Pandit, N. 2005: 2% sodium fluoride-iontophoresis compared to a commercially available desensitizing agent. Journal of Periodontology 76(3): 351-357
Shi, J.; Ray, A.S.; Mathew, J.S.; Anderson, K.S.; Chu, C.K.; Schinazi, R.F. 2004: 2('),3(')-didehydro-2('),3(')-dideoxynucleosides are degraded to furfuryl alcohol under acidic conditions. Bioorganic and Medicinal Chemistry Letters 14(9): 2159-2162
Neelands, T., R.; Burgard, E., C.; Uchic, M., E.; Mcdonald, H., A.; Niforatos, W.; Faltynek, C., R.; Lynch, K., J.; Jarvis, M., F. 2003: 2',3'-O-(2,4,6,Trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor. British Journal of Pharmacology 140(1): 202-210
Gerein, V.; Rastorguev, E.; Gerein, J.; Lodemann, E.; Pfister, H.; Draf, W.; Desloovere, C. 2004: 2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis. Journal of Laryngology and Otology 118(10): 750-756
Sasaki, Y.; Sasaki, A.; Ariizumi, T.; Igari, Y.; Sato, K.; Kohara, H.; Niizuma, H.; Ambo, A. 2004: 2',6'-Dimethylphenylalanine (Dmp) can mimic the N-terminal Tyr in opioid peptides. Biological and Pharmaceutical Bulletin 27(2): 244-247
Han, D.Cho.; Lee, M-Young.; Shin, K.Deok.; Jeon, S.Bok.; Kim, J.Min.; Son, K-Hee.; Kim, H-Chin.; Kim, H-Mook.; Kwon, B-Mog. 2003: 2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species. Journal of Biological Chemistry 279(8): 6911-6920
Giannecchini, M.; D'Innocenzo, B.; Pesi, R.; Sgarrella, F.; Iorio, M.; Collecchi, P.; Tozzi, M.Grazia.; Camici, M. 2004: 2'-Deoxyadenosine causes apoptotic cell death in a human colon carcinoma cell line. Journal of Biochemical and Molecular Toxicology 17(6): 329-337
Kawai, Y.; Uchida, K.; Osawa, T. 2004: 2'-deoxycytidine in free nucleosides and double-stranded DNA as the major target of lipid peroxidation products. Free Radical Biology and Medicine 36(5): 529-541
Roychowdhury, A.; Illangkoon, H.; Hendrickson, C.L.; Benner, S.A. 2004: 2'-deoxycytidines carrying amino and thiol functionality: synthesis and incorporation by Vent (exo-) polymerase. Organic Letters 6(4): 489-492
Schwans, J.P.; Cortez, C.N.; Olvera, J.M.; Piccirilli, J.A. 2003: 2'-mercaptonucleotide interference reveals regions of close packing within folded RNA molecules. Journal of the American Chemical Society 125(33): 10012-10018
Rajeev, K.G.; Prakash, T.P.; Manoharan, M. 2003: 2'-modified-2-thiothymidine oligonucleotides. Organic Letters 5(17): 3005-3008
Koizumi, M. 2004: 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as next-generation antisense and antigene agents. Biological and Pharmaceutical Bulletin 27(4): 453-456
Yoo, B.Hoon.; Bochkareva, E.; Bochkarev, A.; Mou, T-Chung.; Gray, D.M. 2004: 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro. Nucleic Acids Research 32(6): 2008-2016
Bajramovic, J.J.; Volmer, R.; Syan, S.; Pochet, S.; Gonzalez-Dunia, D. 2004: 2'-fluoro-2'-deoxycytidine inhibits Borna disease virus replication and spread. Antimicrobial Agents and Chemotherapy 48(4): 1422-1425
Zatsepin, T.S.; Gait, M.J.; Oretskaya, T.S. 2004: 2'-Functionalized nucleic acids as structural tools in molecular biology. Iubmb Life 56(4): 209-214
Tait, A.; Luppi, A.; Avallone, R.; Baraldi, M. 2005: 2,1,3-Benzothiadiazine derivatives: synthesis and screening versus PDE4 enzyme. Farmaco 60(8): 653-663
Guray, T.; Uysal, U.-Dilek; Gedikbey, T.; Huseyinli, A.A.i 2005: 2,2 ',3,4-Tetrahydroxy-3 '-sulpho-5 '-nitroazobenzene for spectrophotometric determination of aluminium in pharmaceutical suspensions and granite. Analytica Chimica Acta 545(1): 107-112
Mytides, P.; Rozou, S.; Benaki, D.; Antoniadou-Vyza, E. 2006: 2,2 ': 6 ',2 ''-terpyridine 1 : 3 complex used as chelating agent for the determination of iron with a sensitive, selective and fast liquid chromatographic method. Analytica Chimica Acta 566(1): 122-129
Kim, S-Hee.; Kim, Y-Hee.; Shin, K-Joo.; Oh, Y-Seok.; Lee, C.Sup.; Kang, K-Ok.; Ryu, S.Ho.; Suh, P-Ghill. 2004: 2,2',4,6,6'-Pentachlorobiphenyl-induced apoptosis is limited by cyclooxygenase-2 induction. Toxicological Sciences: An Official Journal of the Society of Toxicology 83(2): 397-404
Shin, K-Joo.; Kim, S-Hee.; Kim, D.; Kim, Y-Hee.; Lee, H-Woong.; Chang, Y-Seok.; Gu, M-Bock.; Ryu, S.Ho.; Suh, P-Ghill. 2004: 2,2',4,6,6'-Pentachlorobiphenyl induces mitotic arrest and p53 activation. Toxicological Sciences: An Official Journal of the Society of Toxicology 78(2): 215-221
Syeda, A.; Mahesh, H.R.K.; Syed, A.Ahmed. 2005: 2,2'-Bipyridine as a new and sensitive spectrophotometric reagent for the determination of nanoamounts of certain dibenzazepine class of tricyclic antidepressant drugs. Farmaco 60(1): 47-51
Gao, Z-Guo.; Mamedova, L.; Tchilibon, S.; Gross, A.S.; Jacobson, K.A. 2004: 2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding. Biochemical Pharmacology 68(2): 231-237
Dev, S.; Khan, R.H.; Surolia, A. 2006: 2,2,2-Trifluoroethanol-Induced structural change of peanut agglutinin at different pH: A comparative account. Iubmb Life 58(8): 473-479
Fujishima, T.; Kittaka, A.; Kurihara, M.; Saito, N.; Honzawa, S.; Kishimoto, S.; Sugiura, T.; Waku, K.; Takayama, H. 2004: 2,2-Functionalized analogues of 1alpha,25-dihydroxyvitamin D3, the potent inducers of cell differentiation. Journal of Steroid Biochemistry and Molecular Biology: 89-90(1-5): 89-92
Milczarek, G.; Ciszewski, A. 2004: 2,2-bis(3-amino-4-hydroxyphenyl)hexafluoropropane modified glassy carbon electrodes as selective and sensitive voltammetric sensors. Selective detection of dopamine and uric acid. Electroanalysis 16(23): 1977-1983
Roman-Junior, W.-Antonio; Cardoso, M.-Lane-Carvalho; Vilegas, W.; Nakamura, C.-Vataru; Dias-Filho, B.-Prado; De-Mello, J.-Carlos-Palazzo 2005: 2,3,,4,6-tetra-O-(3-nitropropanoyl)-O-beta-D-glucopyranoside, a new antimicrobial from the roots of Heteropteris aphrodisiaca. Acta Farmaceutica Bonaerense 24(4): 543-545
Yang, M.Young.; Lau, S.S.; Monks, T.J. 2005: 2,3,5-tris(Glutathion-S-yl)hydroquinone (TGHQ)-mediated apoptosis of human promyelocytic leukemia cells is preceded by mitochondrial cytochrome c release in the absence of a decrease in the mitochondrial membrane potential. Toxicological Sciences: An Official Journal of the Society of Toxicology 86(1): 92-100
Schmidt, C.K.; Hoegberg, P.; Fletcher, N.; Nilsson, C.B.; Trossvik, C.; Håkansson, H.; Nau, H. 2003: 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the endogenous metabolism of all-trans-retinoic acid in the rat. Archives of Toxicology 77(7): 371-383
Fletcher, N.; Wahlström, D.; Lundberg, R.; Nilsson, C.B.; Nilsson, K.C.; Stockling, K.; Hellmold, H.; Håkansson, H. 2005: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicology and Applied Pharmacology 207(1): 1-24
Croutch, C.R.; Lebofsky, M.; Schramm, K-Werner.; Terranova, P.F.; Rozman, K.K. 2005: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin (HxCDD) alter body weight by decreasing insulin-like growth factor I (IGF-I) signaling. Toxicological Sciences: An Official Journal of the Society of Toxicology 85(1): 560-571
Kwon, M-Ja.; Jeong, K-Shik.; Choi, E.Jeong.; Lee, B.Ho. 2003: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced activation of mitogen-activated protein kinase signaling pathway in Jurkat T cells. Pharmacology and Toxicology 93(4): 186-190
Park, S-Joon.; Yoon, W-Kee.; Kim, H-Jun.; Son, H-Young.; Cho, S-Whan.; Jeong, K-Shik.; Kim, T-Hwan.; Kim, S-Ho.; Kim, S-Ra.; Ryu, S-Yun. 2005: 2,3,7,8-Tetrachlorodibenzo-p-dioxin activates ERK and p38 mitogen-activated protein kinases in RAW 264.7 cells. Anticancer Research 25(4): 2831-2836
Fisher, M.T.; Nagarkatti, M.; Nagarkatti, P.S. 2004: 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery. Molecular Pharmacology 67(1): 327-335
Mueller, M.D.; Vigne, J-Louis.; Streich, M.; Tee, M.Kian.; Raio, L.; Dreher, E.; Bersinger, N.A.; Taylor, R.N. 2005: 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases glycodelin gene and protein expression in human endometrium. Journal of Clinical Endocrinology and Metabolism 90(8): 4809-4815
Vidal, J.D.; Vandevoort, C.A.; Marcus, C.B.; Lazarewicz, N.R.; Conley, A.J. 2005: 2,3,7,8-tetrachlorodibenzo-p-dioxin induces CYP1B1 expression in human luteinized granulosa cells. Archives of Biochemistry and Biophysics 439(1): 53-60
Boverhof, D.R.; Tam, E.; Harney, A.S.; Crawford, R.B.; Kaminski, N.E.; Zacharewski, T.R. 2004: 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells. Molecular Pharmacology 66(6): 1662-1670
Ivnitski-Steele, I.D.; Sanchez, A.; Walker, M.K. 2004: 2,3,7,8-tetrachlorodibenzo-p-dioxin reduces myocardial hypoxia and vascular endothelial growth factor expression during chick embryo development. Birth Defects Research. Part A Clinical and Molecular Teratology 70(2): 51-58
Kimata, H. 2003: 2,3,7,8-tetrachlorodibenzo-p-dioxin selectively enhances spontaneous IgE production in B cells from atopic patients. International Journal of Hygiene and Environmental Health 206(6): 601-604
Ishida, T.; Kan-o, S.; Mutoh, J.; Takeda, S.; Ishii, Y.; Hashiguchi, I.; Akamine, A.; Yamada, H. 2005: 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced change in intestinal function and pathology: evidence for the involvement of arylhydrocarbon receptor-mediated alteration of glucose transportation. Toxicology and Applied Pharmacology 205(1): 89-97
Novelli, M.; Piaggi, S.; De Tata, V. 2005: 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced impairment of glucose-stimulated insulin secretion in isolated rat pancreatic islets. Toxicology Letters 156(2): 307-314
Villano, C.M.; Murphy, K.A.; Akintobi, A.; White, L.A. 2005: 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicology and Applied Pharmacology 210(3): 212-224
Carney, S.A.; Peterson, R.E.; Heideman, W. 2004: 2,3,7,8-Tetrachlorodibenzo-p-dioxin activation of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator pathway causes developmental toxicity through a CYP1A-independent mechanism in zebrafish. Molecular Pharmacology 66(3): 512-521
Yamada-Okabe, T.; Aono, T.; Sakai, H.; Kashima, Y.; Yamada-Okabe, H. 2004: 2,3,7,8-tetrachlorodibenzo-p-dioxin augments the modulation of gene expression mediated by the thyroid hormone receptor. Toxicology and Applied Pharmacology 194(3): 201-210
Barnes-Ellerbe, S.; Knudsen, K.E.; Puga, A. 2004: 2,3,7,8-Tetrachlorodibenzo-p-dioxin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation. Molecular Pharmacology 66(3): 502-511
Marchand, A.; Tomkiewicz, C.; Marchandeau, J-P.; Boitier, E.; Barouki, R.; Garlatti, M. 2004: 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces insulin-like growth factor binding protein-1 gene expression and counteracts the negative effect of insulin. Molecular Pharmacology 67(2): 444-452
Jin, D-Qing.; Jung, J.Wook.; Lee, Y.Soo.; Kim, J-Ae. 2004: 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits cell proliferation through arylhydrocarbon receptor-mediated G1 arrest in SK-N-SH human neuronal cells. Neuroscience Letters 363(1): 69-72
Lin, T-Min.; Rasmussen, N.T.; Moore, R.W.; Albrecht, R.M.; Peterson, R.E. 2004: 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibits prostatic epithelial bud formation by acting directly on the urogenital sinus. Journal of Urology 172(1): 365-368
Bello, S.M.; Heideman, W.; Peterson, R.E. 2004: 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits regression of the common cardinal vein in developing zebrafish. Toxicological Sciences: An Official Journal of the Society of Toxicology 78(2): 258-266
Kiukkonen, A.; Sahlberg, C.; Lukinmaa, P-Liisa.; Alaluusua, S.; Peltonen, E.; Partanen, A-Maija. 2006: 2,3,7,8-tetrachlorodibenzo-p-dioxin specifically reduces mRNA for the mineralization-related dentin sialophosphoprotein in cultured mouse embryonic molar teeth. Toxicology and Applied Pharmacology 216(3): 399-406
Sulentic, C.E.W.; Zhang, W.; Na, Y.Joo.; Kaminski, N.E. 2004: 2,3,7,8-tetrachlorodibenzo-p-dioxin, an exogenous modulator of the 3'alpha immunoglobulin heavy chain enhancer in the CH12.LX mouse cell line. Journal of Pharmacology and Experimental Therapeutics 309(1): 71-78
Carling, R.W.; Russell, M.G.N.; Moore, K.W.; Mitchinson, A.; Guiblin, A.; Smith, A.; Wafford, K.A.; Marshall, G.; Atack, J.R.; Street, L.J. 2006: 2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists. Bioorganic and Medicinal Chemistry Letters 16(13): 3550-3554
Cociorva, O.M.; Lowary, T.L. 2004: 2,3-Anhydrosugars in glycoside bond synthesis. Application to the preparation of C-2 functionalized alpha-D-arabinofuranosides. Tetrahedron 60(7): 1481-1489, 9 February
Rivera-Molina, Félix.E.; González-Crespo, S.; Maldonado-De la Cruz, Y.; Ortiz-Betancourt, Jé.M.; Rodríguez-Medina, Jé.R. 2006: 2,3-Butanedione monoxime increases sensitivity to Nikkomycin Z in the budding yeast Saccharomyces cerevisiae. World Journal of Microbiology and Biotechnology 22(3): 255-260
Hyup Joo, Y.; Kwan Kim, J.; Kang, S-Hwa.; Noh, M-Soo.; Ha, J-Yong.; Kyu Choi, J.; Lim, K.Min.; Chung, S. 2004: 2,3-Diarylpyran-4-ones: a new series of selective cyclooxygenase-2 inhibitors. Bioorganic and Medicinal Chemistry Letters 14(9): 2195-2198
Ducharme, Y.; Blouin, M.; Carrière, M-Claude.; Chateauneuf, A.; Côté, B.; Denis, D.; Frenette, R.; Greig, G.; Kargman, S.; Lamontagne, S.; Martins, E.; Nantel, Fçois.; O'Neill, G.; Sawyer, N.; Metters, K.M.; Friesen, R.W. 2005: 2,3-Diarylthiophenes as selective EP1 receptor antagonists. Bioorganic and Medicinal Chemistry Letters 15(4): 1155-1160
Severinsen, S.A.; Kirkegaard, M.; Nyengaard, J.R. 2005: 2,3-Dihydroxybenzoic acid attenuates kanamycin-induced volume reduction in mouse utricular type I hair cells. Hearing Research 212(1-2): 99-108
Nogueira, C.W.; Santos, F.W.; Soares, F.A.; Rocha, J.B.T. 2004: 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid, and meso-2,3-dimercaptosuccinic acid inhibit delta-aminolevulinate dehydratase from human erythrocytes in vitro. Environmental Research 94(3): 254-261
Jung, Y-Sik.; Joe, B-Young.; Cho, S.Ju.; Konishi, Y. 2005: 2,3-Dimethoxy-5-methyl-1,4-benzoquinones and 2-methyl-1,4-naphthoquinones: glycation inhibitors with lipid peroxidation activity. Bioorganic and Medicinal Chemistry Letters 15(4): 1125-1129
Hoshina, Y.; Ikegami, S.; Okuyama, A.; Fukui, H.; Inoguchi, K.; Maruyama, T.; Fujimoto, K.; Matsumura, Y.; Aoyama, A.; Harada, T.; Tanaka, H.; Nakamura, T. 2005: 2,3-Diphenylpropionic acids as potent VLA-4 antagonists. Bioorganic and Medicinal Chemistry Letters 15(1): 217-220
Arcadi, A.; Cacchi, S.; Fabrizi, G.; Parisi, L., M. 2004: 2,3-Disubstituted pyrrolo(2,3-b)quinoxalines via aminopalladation-reductive elimination. Tetrahedron Letters 45(11): 2431-2434
Johnson, R.L.; Rao, K.S.S.P. 2004: 2,3-Ethylene- and 2,3-trimethylene-bridged analogues of the group III metabotropic glutamate receptor ligand 2-amino-4-phosphonobutanoic acid. Bioorganic and Medicinal Chemistry Letters 15(1): 57-60
Prasad, C.V.C.; Vig, S.; Smith, D.W.; Gao, Q.; Polson, C.T.; Corsa, J.A.; Guss, V.L.; Loo, A.; Barten, D.M.; Zheng, M.; Felsenstein, K.M.; Roberts, S.B. 2004: 2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of gamma-secretase. Bioorganic and Medicinal Chemistry Letters 14(13): 3535-3538
Przygodzki, T.; Lapshina, E.; Zavodnik, I.; Sokal, A.; Bryszewska, M. 2005: 2,3-Butanedione monoxime does not protect cardiomyocytes under oxidative stress. Cell Biochemistry and Function 24(5): 413-418
Feng, D-Mei.; Wai, J.M.; Kuduk, S.D.; Ng, C.; Murphy, K.L.; Ransom, R.W.; Reiss, D.; Chang, R.S.L.; Harrell, C.M.; MacNeil, T.; Tang, C.; Prueksaritanont, T.; Freidinger, R.M.; Pettibone, D.J.; Bock, M.G. 2005: 2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists. Bioorganic and Medicinal Chemistry Letters 15(9): 2385-2388
Kuduk, S.D.; Ng, C.; Feng, D-Mei.; Wai, J.M-C.; Chang, R.S.L.; Harrell, C.M.; Murphy, K.L.; Ransom, R.W.; Reiss, D.; Ivarsson, M.; Mason, G.; Boyce, S.; Tang, C.; Prueksaritanont, T.; Freidinger, R.M.; Pettibone, D.J.; Bock, M.G. 2004: 2,3-diaminopyridine bradykinin B1 receptor antagonists. Journal of Medicinal Chemistry 47(26): 6439-6442
Courtney, S.M.; Hay, P.A.; Buck, R.T.; Colville, C.S.; Porter, D.W.; Scopes, D.I.C.; Pollard, F.C.; Page, M.J.; Bennett, J.M.; Hircock, M.L.; Mckenzie, E.A.; Stubberfield, C.R.; Turner, P.R. 2004: 2,3-dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors. Bioorganic and Medicinal Chemistry Letters 14(12): 3269-3273
Samuels, N.M.; Klinman, J.P. 2005: 2,4,5-Trihydroxyphenylalanine quinone biogenesis in the copper amine oxidase from Hansenula polymorpha with the alternate metal nickel. Biochemistry 44(43): 14308-14317
Garibay Orijel, C.; Rios Leal, E.; Garcia Mena, J.; Poggi Varaldo, H.M. 2005: 2,4,6-Trichlorophenol and phenol removal in methanogenic and partially-aerated methanogenic conditions in a fluidized bed bioreactor. Journal of Chemical Technology and Biotechnology 80(10): 1180-1187
Sun, Y.; Iemitsu, M.; Shimojo, N.; Miyauchi, T.; Amamiya, M.; Sumi, D.; Hayashi, T.; Sun, G.; Shimojo, N.; Kumagai, Y. 2005: 2,4,6-Trinitrotoluene inhibits endothelial nitric oxide synthase activity and elevates blood pressure in rats. Archives of Toxicology 79(12): 705-710
Jain, M.R.; Zinjarde, S.S.; Deobagkar, D.D.; Deobagkar, D.N. 2004: 2,4,6-trinitrotoluene transformation by a tropical marine yeast, Yarrowia lipolytica NCIM 3589. Marine Pollution Bulletin 49(9-10): 783-788
Agarwal, A.; Kumar, B.; Mehrotra, P.K.; Chauhan, P.M.S. 2005: 2,4,6-Trisubstituted pyrimidine derivatives as pregnancy interceptive agents. Bioorganic and Medicinal Chemistry 13(6): 1893-1899
Chang, L.C.W.; Spanjersberg, R.F.; von Frijtag Drabbe Künzel, J.K.; Mulder-Krieger, T.; van den Hout, G.; Beukers, M.W.; Brussee, J.; Ijzerman, A.P. 2004: 2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists. Journal of Medicinal Chemistry 47(26): 6529-6540
Yoshiizumi, K.; Nakajima, F.; Dobashi, R.; Nishimura, N.; Ikeda, S. 2004: 2,4-Bis(octadecanoylamino)benzenesulfonic acid sodium salt as a novel scavenger receptor inhibitor with low molecular weight. Bioorganic and Medicinal Chemistry Letters 14(11): 2791-2795
Bukowska, B.; Hutnik, K. 2006: 2,4-D and MCPA and their derivatives: Effect on the activity of membrane erythrocytes acetylcholinesterase (in vitro). Pesticide Biochemistry and Physiology 85(3): 174-180
Gonod, L.Vieublé.; Martin-Laurent, F.; Chenu, C. 2006: 2,4-D impact on bacterial communities, and the activity and genetic potential of 2,4-D degrading communities in soil. Fems Microbiology Ecology 58(3): 529-537
Vasudevan, D.; Cooper, E.M. 2004: 2,4-D sorption in iron oxide-rich soils: Role of soil phosphate and exchangeable Al. Environmental Science and Technology 38(1): 163-170
Pez, D.; Leal, I.; Zuccotto, F.; Boussard, C.; Brun, R.; Croft, S.L.; Yardley, V.; Ruiz Perez, L.M.; Gonzalez Pacanowska, D.; Gilbert, I.H. 2003: 2,4-Diaminopyrimidines as inhibitors of leishmanial and trypanosomal dihydrofolate reductase. Bioorganic and Medicinal Chemistry 11(22): 4693-4711
Séverin, I.; Jondeau, A.; Dahbi, L.; Chagnon, M-Christine. 2005: 2,4-Diaminotoluene (2,4-DAT)-induced DNA damage, DNA repair and micronucleus formation in the human hepatoma cell line HepG2. Toxicology 213(1-2): 138-146
Micheli, F.; Di Fabio, R.; Cavanni, P.; Donati, D.; Faedo, S.; Gehanne, S.; Maffeis, M.; Marchioro, C.; Sabbatini, F.Maria.; Tarzia, G.; Tranquillini, M.Elvira.; Viziano, M. 2003: 2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: An exploration of the role of the pyrrolic scaffold. Farmaco 58(10): 1005-1009
Watson, P.S.; Jiang, B.; Harrison, K.; Asakawa, N.; Welch, P.K.; Covington, M.; Stowell, N.C.; Wadman, E.A.; Davies, P.; Solomon, K.A.; Newton, R.C.; Trainor, G.L.; Friedman, S.M.; Decicco, C.P.; Ko, S.S. 2006: 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity. Bioorganic and Medicinal Chemistry Letters 16(21): 5695-5699
Dotzauer, B.; Grünert, R.; Bednarski, P.J.; Lanig, H.; Landwehr, J.; Troschütz, R. 2006: 2,4-Diamino-9H-pyrimido[4,5-b]indol-5-ols: synthesis, in vitro cytotoxic activity, and QSAR investigations. Bioorganic and Medicinal Chemistry 14(21): 7282-7292
Serby, M.D.; Zhao, H.; Szczepankiewicz, B.G.; Kosogof, C.; Xin, Z.; Liu, B.; Liu, M.; Nelson, L.T.J.; Kaszubska, W.; Falls, H.Douglas.; Schaefer, V.; Bush, E.N.; Shapiro, R.; Droz, B.A.; Knourek-Segel, V.E.; Fey, T.A.; Brune, M.E.; Beno, D.W.A.; Turner, T.M.; Collins, C.A.; Jacobson, P.B.; Sham, H.L.; Liu, G. 2006: 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists. Journal of Medicinal Chemistry 49(8): 2568-2578
Thirumurugan, R.; Sriram, D.; Saxena, A.; Stables, J.; Yogeeswari, P. 2006: 2,4-Dimethoxyphenylsemicarbazones with anticonvulsant activity against three animal models of seizures: synthesis and pharmacological evaluation. Bioorganic and Medicinal Chemistry 14(9): 3106-3112
Amigues, E.J.; Migaud, M.E. 2004: 2,4-dinitrophenol as an activating reagent in a facile preparation of cyclic phosphate triesters. Tetrahedron Letters 45(5): 1001-1004, 26 January
Liu, P-Shan.; Chiung, Y-Mei.; Kao, Y-Yun.; Chen, H-Ting. 2005: 2,4-Toluene diisocyanate suppressed the calcium signaling of ligand gated ion channel receptors. Toxicology 219(1-3): 167-174
Wenzel, T.; Sparbier, K.; Mieruch, T.; Kostrzewa, M. 2006: 2,5-Dihydroxyacetophenone: a matrix for highly sensitive matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis of proteins using manual and automated preparation techniques. Rapid Communications in Mass Spectrometry: Rcm 20(5): 785-789
Borthwick, A.D.; Davies, D.E.; Exall, A.M.; Livermore, D.G.; Sollis, S.L.; Nerozzi, F.; Allen, M.J.; Perren, M.; Shabbir, S.S.; Woollard, P.M.; Wyatt, P.G. 2005: 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokinetics. Journal of Medicinal Chemistry 48(22): 6956-6969
Borthwick, A.D.; Davies, D.E.; Exall, A.M.; Hatley, R.J.D.; Hughes, J.A.; Irving, W.R.; Livermore, D.G.; Sollis, S.L.; Nerozzi, F.; Valko, K.L.; Allen, M.J.; Perren, M.; Shabbir, S.S.; Woollard, P.M.; Price, M.A. 2006: 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency. Journal of Medicinal Chemistry 49(14): 4159-4170
Zimmermann, J.; Liebl, R.; von Angerer, E. 2005: 2,5-Diphenylfuran-based pure antiestrogens with selectivity for the estrogen receptor alpha. Journal of Steroid Biochemistry and Molecular Biology 94(1-3): 57-66
Zhang, T-Liang.; Han, X-Ying.; Zhao, X-Lan.; Zhao, L.; Zhang, C-Li.; Yu, L-Hua.; Yu, S-Fang.; Xie, K-Qin. 2005: 2,5-Hexanedione induced reduction in protein content and mRNA expression of neurofilament in rat cerebral cortex. Environmental Toxicology and Pharmacology 20(1): 92-98
Pereira, M.E.; Adams, A.I.H.; Silva, N.S. 2004: 2,5-Hexanedione inhibits rat brain acetylcholinesterase activity in vitro. Toxicology Letters (Shannon) 146(3): 269-274, February 2nd
Markelewicz, R.J.; Hall, S.J.; Boekelheide, K. 2004: 2,5-hexanedione and carbendazim coexposure synergistically disrupts rat spermatogenesis despite opposing molecular effects on microtubules. Toxicological Sciences: An Official Journal of the Society of Toxicology 80(1): 92-100
Zhang, T.; Zhao, X.; Zhu, Z.; Yu, L.; Han, X.; Zhang, C.; Xie, K. 2005: 2,5-hexanedione induced decrease in cytoskeletal proteins of rat sciatic-tibial nerve. Neurochemical Research 30(2): 177-183
LoPachin, R.M.; He, D.; Reid, M.L.; Opanashuk, L.A. 2004: 2,5-Hexanedione-induced changes in the monomeric neurofilament protein content of rat spinal cord fractions. Toxicology and Applied Pharmacology 198(1): 61-73
LoPachin, R.M.; He, D.; Reid, M.L. 2005: 2,5-Hexanedione-induced changes in the neurofilament subunit pools of rat peripheral nerve. Neurotoxicology 26(2): 229-240
Martin, P.M.V.; Martin-Granel, E. 2006: 2,500-year evolution of the term epidemic. Emerging Infectious Diseases 12(6): 976-980
Ahrens, J.ör.; Haeseler, G.; Leuwer, M.; Mohammadi, B.; Krampfl, K.; Dengler, R.; Bufler, J. 2004: 2,6 di-tert-butylphenol, a nonanesthetic propofol analog, modulates alpha1beta glycine receptor function in a manner distinct from propofol. Anesthesia and Analgesia 99(1): 91-96
Tsuzuki, S.; Kawanishi, Y.; Abe, S. 2004: 2,6-diaminopyridine derivatives as models of molecular sensor for nucleic acid base detection: ab initio calculations of electronic effects induced by hydrogen bonds formation. Biosensors and Bioelectronics 20(7): 1452-1457
Carlsson, C.; Fredriksson, A.; Brandt, I. 2003: 2,6-Dichlorophenyl methylsulphone induced behavioural impairments in rats and mice in relation to olfactory mucosal metaplasia. Pharmacology and Toxicology 93(4): 156-168
Henderson, A.P.; Bleasdale, C.; Clegg, W.; Golding, B.T. 2004: 2,6-diarylaminotetrahydropyrans from reactions of glutaraldehyde with anilines: models for biomolecule cross-linking. Chemical Research in Toxicology 17(3): 378-382
Wang, H.; Liu, X.; Zhang, N.; Cao, L-Wei.; Zhang, H-Shan. 2006: 2,6-dimethyl-4-quinolinecarboxylic acid N-hydroxysuccinimide ester: A fluorogenic hydrophilic derivatizing reagent for liquid chromatographic analysis of aliphatic amines. Journal of Separation Science 29(5): 635-640
Chang, L.C.W.; Spanjersberg, R.F.; von Frijtag Drabbe Künzel, J.K.; Mulder-Krieger, T.; Brussee, J.; Ijzerman, A.P. 2006: 2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists. Journal of Medicinal Chemistry 49(10): 2861-2867
Liot, Géraldine.; Benchenane, K.; Léveillé, Fédéric.; López-Atalaya, Jé.P.; Fernández-Monreal, Mónica.; Ruocco, A.; Mackenzie, E.T.; Buisson, A.; Ali, C.; Vivien, D. 2004: 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 24(10): 1153-1159
Stefańska, B.; Bontemps-Gracz, M.M.; Antonini, I.; Martelli, S.; Arciemiuk, Młgorzata.; Piwkowska, A.; Rogacka, D.; Borowski, E. 2005: 2,7-Dihydro-3H-pyridazino[5,4,3-kl]acridin-3-one derivatives, novel type of cytotoxic agents active on multidrug-resistant cell lines. Synthesis and biological evaluation. Bioorganic and Medicinal Chemistry 13(6): 1969-1975
Shiba, M.; Shimizu, K.; Takatera, H. 2003: 2,8-dihydoroxyadenine (DHA) urolithiasis: a case report. Hinyokika Kiyo. Acta Urologica Japonica 49(8): 497-499
Arnadottir, M.; Laxdal, Töstur.; Halldorsdottir, B. 2005: 2,8-dihydroxyadeninuria: are there no cases in Scandinavia?. Scandinavian Journal of Urology and Nephrology 39(1): 82-86
Biagi, G.; Bianucci, A.Maria.; Coi, A.; Costa, B.; Fabbrini, L.; Giorgi, I.; Livi, O.; Micco, I.; Pacchini, F.; Santini, E.; Leonardi, M.; Nofal, F.Ahmad.; Salerni, O.LeRoy.; Scartoni, V. 2005: 2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies. Bioorganic and Medicinal Chemistry 13(15): 4679-4693
Pavlovic, S.; Schulze, G.; Wernicke, C.; Bonnet, R.; Gille, G.; Badiali, L.; Kaminska, A.; Lorenc-Koci, E.; Ossowska, K.; Rommelspacher, H. 2006: 2,9-Dimethyl-beta-carbolinium, a neurotoxin occurring in human brain, is a potent inducer of apoptosis as 1-methyl-4-phenylpyridinium. Neuroscience 139(4): 1525-1537
Wang, S.Chi.; Chung, J-Gung.; Chen, C-Hsein.; Chen, S-Ching. 2005: 2- and 4-Aminobiphenyls induce oxidative DNA damage in human hepatoma (Hep G2) cells via different mechanisms. Mutation Research 593(1-2): 9-21
Kiselyov, A.S.; Semenova, M.; Semenov, V.V.; Piatnitski, E. 2005: 2-((1H-Azol-1-yl)methyl)-N-arylbenzamides: novel dual inhibitors of VEGFR-1/2 kinases. Bioorganic and Medicinal Chemistry Letters 16(6): 1726-1730
Sakamoto, I.; Izumi, N.; Yamada, T.; Tsunoda, T. 2006: 2-(1,3-dioxan-2-yl)ethylsulfonyl group: A new versatile protecting and activating group for amine synthesis. Organic Letters 8(1): 71-74
Konno, T.; Uchibori, T.; Nagai, A.; Kogi, K.; Nakahata, N. 2005: 2-(1-Hexyn-1-yl)adenosine-induced intraocular hypertension is mediated via K+ channel opening through adenosine A2A receptor in rabbits. European Journal of Pharmacology 518(2-3): 203-211
Zhang, Y.; Wang, L.; Li, J.; Wang, X-Liang. 2006: 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia. Journal of Pharmacology and Experimental Therapeutics 317(3): 973-979
Horvath, A.; Nussbaumer, P.; Wolff, B.; Billich, A. 2004: 2-(1-adamantyl)-4-(thio)chromenone-6-carboxylic acids: potent reversible inhibitors of human steroid sulfatase. Journal of Medicinal Chemistry 47(17): 4268-4276
Konishi, J.; Maruhashi, K. 2003: 2-(2'-Hydroxyphenyl)benzene sulfinate desulfinase from the thermophilic desulfurizing bacterium Paenibacillus sp. strain A11-2: purification and characterization. Applied Microbiology and Biotechnology 62(4): 356-361
Frydenvang, K.; Sommer, M.Bech.; Heckmann, D.; Nielsen, O.; Bang-Andersen, B. 2004: 2-(2,3-Dihydro-1H-indol-3-yl)ethanol: synthesis, separation of enantiomers, and assignment of absolute stereochemistry by X-ray structure analysis. Chirality 16(2): 126-130
Rao, A.; Balzarini, J.; Carbone, A.; Chimirri, A.; De Clercq, E.; Monforte, A.M.; Monforte, P.; Pannecouque, C.; Zappalà, M. 2004: 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors. Antiviral Research 63(2): 79-84
Kung, H.F.; Newman, S.; Choi, S-Rye.; Oya, S.; Hou, C.; Zhuang, Z-Ping.; Acton, P.D.; Plössl, K.; Winkler, J.; Kung, M-Ping. 2004: 2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent. Journal of Medicinal Chemistry 47(21): 5258-5264
Wu, C-Chung.; Wang, T-Wei.; Wang, W-Ya.; Hsieh, P-Wen.; Wu, Y-Chang. 2005: 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. European Journal of Pharmacology 527(1-3): 37-43
Matasi, J.J.; Caldwell, J.P.; Zhang, H.; Fawzi, A.; Higgins, G.A.; Cohen-Williams, M.E.; Varty, G.B.; Tulshian, D.B. 2005: 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2. Bioorganic and Medicinal Chemistry Letters 15(16): 3675-3678
Matasi, J.J.; Caldwell, J.P.; Zhang, H.; Fawzi, A.; Cohen-Williams, M.E.; Varty, G.B.; Tulshian, D.B. 2005: 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: highly potent, orally active, adenosine A2A antagonists. Part 1. Bioorganic and Medicinal Chemistry Letters 15(16): 3670-3674
Ghosh, S.Kumar.; Hossain, S.Ugir.; Bhattacharya, S.; Bhattacharya, S.Chandra. 2005: 2-(2-Selenocyanic acid ethyl ester)-1H-benz[de] isoquinoline-1,3-(2H)-dione, synthesis photophysics and interaction with bovine serum albumin: a spectroscopic approach. Journal of Photochemistry and Photobiology. B Biology 81(2): 121-128
Koch, U.; Attenni, B.; Malancona, S.; Colarusso, S.; Conte, I.; Di Filippo, M.; Harper, S.; Pacini, B.; Giomini, C.; Thomas, S.; Incitti, I.; Tomei, L.; De Francesco, R.; Altamura, S.; Matassa, V.G.; Narjes, F. 2006: 2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: discovery, SAR, modeling, and mutagenesis. Journal of Medicinal Chemistry 49(5): 1693-1705
Popsavin, M.; Spaić, S.; Svircev, M.; Kojić, V.; Bogdanović, G.; Popsavin, V. 2006: 2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity. Bioorganic and Medicinal Chemistry Letters 16(20): 5317-5320
Saczewski, F.; Hudson, A.L.; Tyacke, R.J.; Nutt, D.J.; Man, J.; Tabin, P.; Saczewski, J. 2003: 2-(4,5-dihydro-1H-imidazol-2-yl)indazole (indazim) derivatives as selective I(2) imidazoline receptor ligands. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 20(2): 201-208
Saczewski, F.; Tabin, P.; Tyacke, R.J.; Maconie, A.; Saczewski, Jław.; Kornicka, A.; Nutt, D.J.; Hudson, A.L. 2006: 2-(4,5-Dihydroimidazol-2-yl)benzimidazoles as highly selective imidazoline I2/adrenergic alpha2 receptor ligands. Bioorganic and Medicinal Chemistry 14(19): 6679-6685
Zaragoza, F.; Stephensen, H.; Peschke, B.; Rimvall, K. 2005: 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists. Journal of Medicinal Chemistry 48(1): 306-311
Nielsen, F.E.; Jacobsen, P.; Worsaae, A.; Arkhammar, P.O.G.; Wahl, P.; Bondo Hansen, J. 2004: 2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide activates Kir6.2/SUR1 K(ATP) channels. Bioorganic and Medicinal Chemistry Letters 14(23): 5727-5730
Ahn, H.Jun.; Koketsu, M.; Yang, E.Mi.; Kim, Y.Man.; Ishihara, H.; Yang, H.Ok. 2006: 2-(4-Methylphenyl)-1,3-selenazol-4-one induces apoptosis by different mechanisms in SKOV3 and HL 60 cells. Journal of Cellular Biochemistry 99(3): 807-815
Rawal, R.K.; Prabhakar, Y.S.; Katti, S.B.; De Clercq, E. 2005: 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors. Bioorganic and Medicinal Chemistry 13(24): 6771-6776
Mazurov, A.; Klucik, J.; Miao, L.; Phillips, T.Y.; Seamans, A.; Schmitt, J.D.; Hauser, T.A.; Johnson, R.T.; Miller, C. 2005: 2-(Arylmethyl)-3-substituted quinuclidines as selective alpha 7 nicotinic receptor ligands. Bioorganic and Medicinal Chemistry Letters 15(8): 2073-2077
Novellino, E.; Cosimelli, B.; Ehlardo, M.; Greco, G.; Iadanza, M.; Lavecchia, A.; Rimoli, M.Grazia.; Sala, A.; Da Settimo, A.; Primofiore, G.; Da Settimo, F.; Taliani, S.; La Motta, C.; Klotz, K-Norbert.; Tuscano, D.; Trincavelli, M.Letizia.; Martini, C. 2005: 2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching. Journal of Medicinal Chemistry 48(26): 8253-8260
Mazzei, M.; Nieddu, E.; Folli, C.; Caci, E.; Galietta, L.V.J. 2003: 2-(Dialkylamino)-4H-1-benzopyran-4-one derivatives modify chloride conductance in CFTR expressing cells. Farmaco 58(9): 961-970
Carrasco, M.R.; Brown, R.T.; Doan, V.H.; Kandel, S.M.; Lee, F.C. 2006: 2-(N-Fmoc)-3-(N-Boc-N-methoxy)-diaminopropanoic acid, an amino acid for the synthesis of mimics of O-linked glycopeptides. Biopolymers 84(4): 414-420
Jagtap, P.G.; Chen, Z.; Szabó, C.; Klotz, K-Norbert. 2004: 2-(N-acyl) and 2-N-acyl-N(6)-substituted analogues of adenosine and their affinity at the human adenosine receptors. Bioorganic and Medicinal Chemistry Letters 14(6): 1495-1498
Wissner, A.; Floyd, M.Brawner.; Johnson, B.D.; Fraser, H.; Ingalls, C.; Nittoli, T.; Dushin, R.G.; Discafani, C.; Nilakantan, R.; Marini, J.; Ravi, M.; Cheung, K.; Tan, X.; Musto, S.; Annable, T.; Siegel, M.M.; Loganzo, F. 2005: 2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2. Journal of Medicinal Chemistry 48(24): 7560-7581
Prisinzano, T.; Dukat, Młgorzata.; Law, H.; Slassi, A.; MacLean, N.; DeLannoy, Iés.; Glennon, R.A. 2004: 2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT1D serotonin receptor ligands. Bioorganic and Medicinal Chemistry Letters 14(18): 4697-4699
Singh, K.; Behal, S.; Deb, P., K. 2004: 2-(arylsulfinylmethyl)oxazinanes: chiral carbonyl equivalents. Application to the asymmetric synthesis of 1,2,3,4-tetrahydro-beta-carbolines. Tetrahedron 60(41): 9171-9177
Liang, S.-Cai; Wang, H.; Zhang, Z.-Min; Zhang, H.-Shan 2005: 2-(p-iodoacetylaminophenyl)benzothiazole: A pre-column fluorescent derivatizing reagent for thiol in liquid chromatography. Analytical Letters 38(5): 869-879
Karramkam, M.; Hinnen, F.; Vaufrey, F.; Dolle, F. 2003: 2-, 3- and 4-(18F)Fluoropyridine by no-carrier-added nucleophilic aromatic substitution with K(18F)F-K222: A comparative study. Journal of Labelled Compounds and Radiopharmaceuticals 46(10): 979-992
Nakanishi, M.; Goto, Y.; Kitade, Y. 2005: 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L. Proteins 60(1): 131-138
Hoogervorst, E.M.; van Oostrom, C.Th.M.; Beems, R.B.; van Benthem, J.; van den Berg, J.; van Kreijl, C.F.; Vos, J.G.; de Vries, A.; van Steeg, H. 2004: 2-AAF-induced tumor development in nucleotide excision repair-deficient mice is associated with a defect in global genome repair but not with transcription coupled repair. Dna Repair 4(1): 3-9
Lemonnier, L.; Prevarskaya, N.; Mazurier, J.; Shuba, Y.; Skryma, R. 2004: 2-APB inhibits volume-regulated anion channels independently from intracellular calcium signaling modulation. FEBS Letters 556(1-3): 121-126
Martín, Jé.A.; Brooks, D.A.; Prieto, L.; González, R.; Torrado, A.; Rojo, I.; López de Uralde, B.; Lamas, C.; Ferritto, R.; Dolores Martín-Ortega, Mía.; Agejas, J.; Parra, F.; Rizzo, J.R.; Rhodes, G.A.; Robey, R.L.; Alt, C.A.; Wendel, S.R.; Zhang, T.Y.; Reifel-Miller, A.; Montrose-Rafizadeh, C.; Brozinick, J.T.; Hawkins, E.; Misener, E.A.; Briere, D.A.; Ardecky, R.; Fraser, J.D.; Warshawsky, A.M. 2005: 2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents. Bioorganic and Medicinal Chemistry Letters 15(1): 51-55
Mattsson, C.; Sonesson, C.; Sandahl, A.; Greiner, H.E.; Gassen, M.; Plaschke, Jörg.; Leibrock, J.; Böttcher, H. 2005: 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists. Bioorganic and Medicinal Chemistry Letters 15(19): 4230-4234
Zamora, R.; Hidalgo, F.J. 2005: 2-Alkylpyrrole formation from 4,5-epoxy-2-alkenals. Chemical Research in Toxicology 18(2): 342-348
Tuesuwan, B.; Kerwin, S.M. 2006: 2-Alkynyl-N-propargyl pyridinium salts: pyridinium-based heterocyclic skipped aza-enediynes that cleave DNA by deoxyribosyl hydrogen-atom abstraction and guanine oxidation. Biochemistry 45(23): 7265-7276
Banerjee, H.N.; Verma, M.; Dutta, S.K. 2004: 2-Am,4,6-DNT causes genotoxicity of p53 gene in NG108 neuroblastoma cell lines. International Journal of Human Genetics 4(4): 227-229
Andreassen, A.; Vikse, R.; Mikalsen, A.; Adamovic, T.; Steffensen, I-L.; Hjertholm, H.; Levan, G.; Alexander, J. 2006: 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation. Mutation Research 604(1-2): 60-70
Fukuda, G.; Yoshitake, N.; Khan, Z.Ali.; Kanazawa, M.; Notoya, Y.; Che, X-Fang.; Akiyama, S-ichi.; Tomoda, A.; Chakrabarti, S.; Odawara, M. 2005: 2-Amino-phenoxazine-3-one attenuates glucose-induced augmentation of embryonic form of myosin heavy chain, endothelin-1 and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. Biological and Pharmaceutical Bulletin 28(5): 797-801
Ratz, P.H.; Berg, K.M. 2006: 2-Aminoethoxydiphenyl borate inhibits KCl-induced vascular smooth muscle contraction. European Journal of Pharmacology 541(3): 177-183
Gu, Q.; Lin, R-Lung.; Hu, H-Zhen.; Zhu, M.X.; Lee, L-Yuan. 2005: 2-aminoethoxydiphenyl borate stimulates pulmonary C neurons via the activation of TRPV channels. American Journal of Physiology. Lung Cellular and Molecular Physiology 288(5): L932-L941
Dibrov, P.; Rimon, A.; Dzioba, J.; Winogrodzki, A.; Shalitin, Y.; Padan, E. 2005: 2-Aminoperimidine, a specific inhibitor of bacterial NhaA Na(+)/H(+) antiporters. Febs Letters 579(2): 373-378
Bathini, Y.; Singh, I.; Harvey, P.J.; Keller, P.R.; Singh, R.; Micetich, R.G.; Fry, D.W.; Dobrusin, E.M.; Toogood, P.L. 2005: 2-Aminoquinazoline inhibitors of cyclin-dependent kinases. Bioorganic and Medicinal Chemistry Letters 15(17): 3881-3885
Jiang, J.; Hoang, M.; Young, J.R.; Chaung, D.; Eid, R.; Turner, C.; Lin, P.; Tong, X.; Wang, J.; Tan, C.; Feighner, S.; Palyha, O.; Hreniuk, D.L.; Pan, J.; Sailer, A.W.; MacNeil, D.J.; Howard, A.; Shearman, L.; Stribling, S.; Camacho, R.; Strack, A.; Van der Ploeg, L.H.T.; Goulet, M.T.; DeVita, R.J. 2006: 2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonists. Bioorganic and Medicinal Chemistry Letters 16(20): 5270-5274
Nikolakopoulos, G.; Figler, H.; Linden, J.; Scammells, P.J. 2005: 2-Aminothiophene-3-carboxylates and carboxamides as adenosine A1 receptor allosteric enhancers. Bioorganic and Medicinal Chemistry 14(7): 2358-2365
Argirov, O.K.; Lin, B.; Ortwerth, B.J. 2003: 2-ammonio-6-(3-oxidopyridinium-1-yl)hexanoate (OP-lysine) is a newly identified advanced glycation end product in cataractous and aged human lenses. Journal of Biological Chemistry 279(8): 6487-6495
Wang, S.; Meades, C.; Wood, G.; Osnowski, A.; Anderson, S.; Yuill, R.; Thomas, M.; Mezna, M.; Jackson, W.; Midgley, C.; Griffiths, G.; Fleming, I.; Green, S.; McNae, I.; Wu, S-Ying.; McInnes, C.; Zheleva, D.; Walkinshaw, M.D.; Fischer, P.M. 2004: 2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activity. Journal of Medicinal Chemistry 47(7): 1662-1675
Suzuki, T.; Imai, K.; Nakagawa, H.; Miyata, N. 2006: 2-Anilinobenzamides as SIRT inhibitors. Chemmedchem 1(10): 1059-1062
Kaplan, B.L.F.; Ouyang, Y.; Rockwell, C.E.; Rao, G.K.; Kaminski, N.E. 2005: 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2. Journal of Leukocyte Biology 77(6): 966-974
Gokoh, M.; Kishimoto, S.; Oka, S.; Metani, Y.; Sugiura, T. 2005: 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes. Febs Letters 579(28): 6473-6478
Gokoh, M.; Kishimoto, S.; Oka, S.; Mori, M.; Waku, K.; Ishima, Y.; Sugiura, T. 2004: 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells. Biochemical Journal 386(Pt 3): 583-589
Oka, S.; Ikeda, S.; Kishimoto, S.; Gokoh, M.; Yanagimoto, S.; Waku, K.; Sugiura, T. 2004: 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. Journal of Leukocyte Biology 76(5): 1002-1009
Nithipatikom, K.; Endsley, M.P.; Isbell, M.A.; Falck, J.R.; Iwamoto, Y.; Hillard, C.J.; Campbell, W.B. 2004: 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Research 64(24): 8826-8830
Cacchi, S.; Fabrizi, G.; Parisi, L.M. 2003: 2-Aryl and 2-heteroaryl indoles from 1-alkynes and o-iodotrifluoroacetanilide through a domino copper-catalyzed coupling-cyclization process. Organic Letters 5(21): 3843-3846
Dubowchik, G.M.; Michne, J.A.; Zuev, D.; Schwartz, W.; Scola, P.M.; James, C.A.; Ruediger, E.H.; Pin, S.S.; Burris, K.D.; Balanda, L.A.; Gao, Q.; Wu, D.; Fung, L.; Fiedler, T.; Browman, K.E.; Taber, M.T.; Zhang, J. 2003: 2-Arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: Synthesis, binding studies and behavioral efficacy. Bioorganic and Medicinal Chemistry Letters 13(22): 3997-4000
Husain, A.; Khan, M.S.Y.; Hasan, S.M.; Alam, M.M. 2005: 2-Arylidene-4-(4-phenoxy-phenyl)but-3-en-4-olides: synthesis, reactions and biological activity. European Journal of Medicinal Chemistry 40(12): 1394-1404
Allegretti, M.; Bertini, R.; Cesta, M.Candida.; Bizzarri, C.; Di Bitondo, R.; Di Cioccio, V.; Galliera, E.; Berdini, V.; Topai, A.; Zampella, G.; Russo, V.; Di Bello, N.; Nano, G.; Nicolini, L.; Locati, M.; Fantucci, P.; Florio, S.; Colotta, F. 2005: 2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors. Journal of Medicinal Chemistry 48(13): 4312-4331
Valgeirsson, J.; Nielsen, E.Ø.; Peters, D.; Varming, T.; Mathiesen, C.; Kristensen, A.S.; Madsen, U. 2003: 2-arylureidobenzoic acids: selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5. Journal of Medicinal Chemistry 46(26): 5834-5843
Lee, J.; Lee, J-Hyun.; Kim, S.Yeon.; Perry, N.A.; Lewin, N.E.; Ayres, J.A.; Blumberg, P.M. 2005: 2-Benzyl and 2-phenyl-3-hydroxypropyl pivalates as protein kinase C ligands. Bioorganic and Medicinal Chemistry 14(6): 2022-2031
Wang, J-Pyang.; Chang, L-Chu.; Kuan, Y-Hsiang.; Tsao, L-Ti.; Huang, L-Jiau.; Kuo, S-Chu. 2004: 2-Benzyloxybenzaldehyde inhibits formyl peptide-stimulated increase in intracellular Ca2+ in neutrophils mainly by blocking Ca2+ entry. Naunyn-Schmiedeberg's Archives of Pharmacology 370(5): 353-360
Shao, H.; Ekthawatchai, S.; Wu, S-Hsiung.; Zou, W. 2004: 2-C-branched glycosides from 2'-carbonylalkyl 2-O-Ms(Ts)-C-glycosides. A tandem SN2-SN2 reaction via 1,2-cyclopropanated sugars. Organic Letters 6(20): 3497-3499
Zhu, X.; Liu, Q.; Jiang, C. 2006: 2-Carboxy-1-naphthyl phosphate as a substrate for the fluorimetric determination of alkaline phosphatase. Analytica Chimica Acta 570(1): 29-33
Han, T.; Fernandez, M.; Chou, T-Chao.; Agarwal, R.P. 2004: 2-Chloro-2'-deoxyadenosine synergistically enhances azidothymidine cytotoxicity in azidothymidine resistant T-lymphoid cells. Biochemical and Biophysical Research Communications 316(2): 518-522
Colleoni, G.W.B.; Duarte, L.Cláudio.C.; Kerbauy, Fábio.Rodrigues.; Lobão, M.; Yunis, M.Palis.; Alves, A.Correa.; de Souza, V.Akiko.Ueda.Fick.; Bordin, Jé.Orlando.; de Oliveira, Jé.Salvador.R. 2003: 2-Chloro-deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to non-Hodgkin's lymphoma. Acta Oncologica 42(7): 784-787
Rogalińska, M.; Błoński, J.Z.; Hanausek, M.; Walaszek, Z.; Robak, T.; Kiliańska, Z.M. 2004: 2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo. Cancer Detection and Prevention 28(6): 433-442
Marsche, G.; Heller, R.; Fauler, Günter.; Kovacevic, A.; Nuszkowski, A.; Graier, W.; Sattler, W.; Malle, E. 2004: 2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis. Arteriosclerosis Thrombosis and Vascular Biology 24(12): 2302-2306
D'Ambrosi, N.; Costanzi, S.; Angelini, D.F.; Volpini, R.; Sancesario, G.; Cristalli, G.; Volonté, C. 2004: 2-ClATP exerts anti-tumoural actions not mediated by P2 receptors in neuronal and glial cell lines. Biochemical Pharmacology 67(4): 621-630
Yano, K.; Komaki-Yasuda, K.; Tsuboi, T.; Torii, M.; Kano, S.; Kawazu, S-ichiro. 2006: 2-Cys Peroxiredoxin TPx-1 is involved in gametocyte development in Plasmodium berghei. Molecular and Biochemical Parasitology 148(1): 44-51
Kang, S.Won.; Rhee, S.Goo.; Chang, T-Shin.; Jeong, W.; Choi, M.Hee. 2005: 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends in Molecular Medicine 11(12): 571-578
Tan, H.Tong.; Zubaidah, R.M.; Tan, S.; Hooi, S.Chuan.; Chung, M.C.M. 2006: 2-D DIGE analysis of butyrate-treated HCT-116 cells after enrichment with heparin affinity chromatography. Journal of Proteome Research 5(5): 1098-1106
Helling, S.; Schmitt, E.; Joppich, C.; Schulenborg, T.; Müllner, S.; Felske-Müller, S.; Wiebringhaus, T.; Becker, G.; Linsenmann, G.; Sitek, B.; Lutter, P.; Meyer, H.E.; Marcus, K. 2006: 2-D differential membrane proteome analysis of scarce protein samples. Proteomics 6(16): 4506-4513
Li, C.; Hu, J. 2006: 2-D graphical representation for characteristic sequences of DNA and its application. Journal of Biochemistry and Molecular Biology 39(3): 292-296
Randić, M. 2004: 2-D graphical representation of proteins based on virtual genetic code. Sar and Qsar in Environmental Research 15(3): 147-157
Gonzalez, L.; Bustamante, J.J.; Barea-Rodriguez, E.J.; Martinez, A.O.; Haro, L.S. 2006: 2-D native-PAGE/SDS-PAGE visualization of an oligomer's subunits: application to the analysis of IgG. Electrophoresis 27(10): 2016-2023
Gelfi, C.; Viganò, A.; De Palma, S.; Ripamonti, M.; Begum, S.; Cerretelli, P.; Wait, R. 2005: 2-D protein maps of rat gastrocnemius and soleus muscles: a tool for muscle plasticity assessment. Proteomics 6(1): 321-340
Wang, J.; Ying, T.; Wang, H.; Shi, Z.; Li, M.; He, K.; Feng, E.; Wang, J.; Yuan, J.; Li, T.; Wei, K.; Su, G.; Zhu, H.; Zhang, X.; Huang, P.; Huang, L. 2005: 2-D reference map of Bacillus anthracis vaccine strain A16R proteins. Proteomics 5(17): 4488-4495
Chen, C-Jen.; Chang, R-Feng.; Moon, W.Kyung.; Chen, D-Ren.; Wu, H-Koon. 2006: 2-D ultrasound strain images for breast cancer diagnosis using nonrigid subregion registration. Ultrasound in Medicine and Biology 32(6): 837-846
Lundgren, C.; Lahmann, J.; Becker, S.; Roblick, U.; Schedvins, K.; Boman, K.; Frankendal, B.; Nordström, B.; Auer, G. 2006: 2-DE protein expression in endometrial carcinoma. Acta Oncologica 45(6): 685-694
Hoffrogge, R.; Mikkat, S.; Scharf, C.; Beyer, S.; Christoph, H.; Pahnke, J.; Mix, E.; Berth, M.; Uhrmacher, A.; Zubrzycki, I.Z.; Miljan, E.; Völker, U.; Rolfs, A. 2006: 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 6(6): 1833-1847
Ikeda, K.; Sato, K.; Kitani, S.; Suzuki, T.; Maki, N.; Suzuki, Y.; Sato, M. 2006: 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1. Bioorganic and Medicinal Chemistry 14(23): 7893-7897
Lan, Y-Wen.; Ishii, Y.; Palmer, K.E.; Bristow, K.Q.; Caprioli, J.; Kwong, J.M.K. 2003: 2-Deoxy-D-glucose protects retinal ganglion cells against excitotoxicity. Neuroreport 14(18): 2369-2372
Ikeda, R.; Che, X-Fang.; Ushiyama, M.; Yamaguchi, T.; Okumura, H.; Nakajima, Y.; Takeda, Y.; Shibayama, Y.; Furukawa, T.; Yamamoto, M.; Haraguchi, M.; Sumizawa, T.; Yamada, K.; Akiyama, S-ichi. 2006: 2-Deoxy-D-ribose inhibits hypoxia-induced apoptosis by suppressing the phosphorylation of p38 MAPK. Biochemical and Biophysical Research Communications 342(1): 280-285
Nakajima, Y.; Haraguchi, M.; Furukawa, T.; Yamamoto, M.; Nakanishi, H.; Tatematsu, M.; Akiyama, S-ichi. 2006: 2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9. International Journal of Cancer 119(7): 1710-1716
Zhu, Z.; Jiang, W.; McGinley, J.N.; Thompson, H.J. 2005: 2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. Cancer Research 65(15): 7023-7030
Grieb, P.; Gordon-Krajcer, W.; Frontczak-Baniewicz, Młgorzata.; Walski, Mł.; Ryba, M.S.; Kryczka, T.; Fiedorowicz, M.; Kulinowski, P.; Sułek, Z.; Majcher, K.; Jasiński, A. 2004: 2-deoxyglucose induces beta-APP overexpression, tau hyperphosphorylation and expansion of the trans-part of the Golgi complex in rat cerebral cortex. Acta Neurobiologiae Experimentalis 64(4): 491-502
Kang, H.Tae.; Hwang, E.Seong. 2005: 2-Deoxyglucose: an anticancer and antiviral therapeutic, but not any more a low glucose mimetic. Life Sciences 78(12): 1392-1399
Reed, J.E.; Woo, L.W.Lawrence.; Robinson, J.J.; Leblond, B.; Leese, M.P.; Purohit, A.; Reed, M.J.; Potter, B.V.L. 2004: 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor. Biochemical and Biophysical Research Communications 317(1): 169-175
Chassaigne, H.; Chery, C.C.; Bordin, G.; Vanhaecke, F.; Rodriguez, A.R. 2004: 2-Dimensional gel electrophoresis technique for yeast selenium-containing proteins: Sample preparation and MS approaches for processing 2-D gel protein spots. Journal of Analytical Atomic Spectrometry 19(1): 85-95
Brown, R.N.; Cameron, R.; Chalmers, D.K.; Hamilton, S.; Luttick, A.; Krippner, G.Y.; McConnell, D.B.; Nearn, R.; Stanislawski, P.C.; Tucker, S.P.; Watson, K.G. 2005: 2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder. Bioorganic and Medicinal Chemistry Letters 15(8): 2051-2055
Korman, S.H.; Andresen, B.S.; Zeharia, A.; Gutman, A.; Boneh, A.; Pitt, J.J. 2004: 2-ethylhydracrylic aciduria in short/branched-chain acyl-CoA dehydrogenase deficiency: application to diagnosis and implications for the R-pathway of isoleucine oxidation. Clinical Chemistry 51(3): 610-617
McGuire, J.J.; Saifeddine, M.; Triggle, C.R.; Sun, K.; Hollenberg, M.D. 2004: 2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist. Journal of Pharmacology and Experimental Therapeutics 309(3): 1124-1131
Higashi, T.; Yamauchi, A.; Shimada, K. 2005: 2-hydrazino-1-methylpyridine: a highly sensitive derivatization reagent for oxosteroids in liquid chromatography-electrospray ionization-mass spectrometry. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 825(2): 214-222
Marzin, D.; Kirkland, D. 2004: 2-Hydroxy-1,4-naphthoquinone, the natural dye of Henna, is non-genotoxic in the mouse bone marrow micronucleus test and does not produce oxidative DNA damage in Chinese hamster ovary cells. Mutation Research 560(1): 41-47
Baindur, N.; Chadha, N.; Brandt, B.M.; Asgari, D.; Patch, R.J.; Schalk-Hihi, C.; Carver, T.E.; Petrounia, I.P.; Baumann, C.A.; Ott, H.; Manthey, C.; Springer, B.A.; Player, M.R. 2005: 2-Hydroxy-4,6-diamino-[1,3,5]triazines: a novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors. Journal of Medicinal Chemistry 48(6): 1717-1720
Nihei, K-ichi.; Yamagiwa, Y.; Kamikawa, T.; Kubo, I. 2004: 2-Hydroxy-4-isopropylbenzaldehyde, a potent partial tyrosinase inhibitor. Bioorganic and Medicinal Chemistry Letters 14(3): 681-683
Zacharia, L.C.; Piché, C.A.; Fielding, R.M.; Holland, K.M.; Allison, S.Dean.; Dubey, R.K.; Jackson, E.K. 2004: 2-hydroxyestradiol is a prodrug of 2-methoxyestradiol. Journal of Pharmacology and Experimental Therapeutics 309(3): 1093-1097
Mustafa, K'Ain.; Perry, N.B.; Weavers, R.T. 2003: 2-Hydroxyflavanones from Leptospermum polygalifolium subsp. polygalifolium Equilibrating sets of hemiacetal isomers. Phytochemistry 64(7): 1285-1293
Alemany, R.; Terés, S.; Baamonde, C.; Benet, M.; Vögler, O.; Escribá, P.V. 2003: 2-hydroxyoleic acid: a new hypotensive molecule. Hypertension 43(2): 249-254
Casulli, A.; Morales, M.Angeles.Gomez.; Gallinella, B.; Turchetto, L.; Pozio, E. 2006: 2-Hydroxypropyl-beta-cyclodextrin improves the effectiveness of albendazole against encapsulated larvae of Trichinella spiralis in a murine model. Journal of Antimicrobial ChemoTherapy 58(4): 886-890
Hu, C-Long.; Liu, Z.; Gao, Z-Yu.; Zhang, Z-Hong.; Mei, Y-Ai. 2004: 2-iodomelatonin prevents apoptosis of cerebellar granule neurons via inhibition of A-type transient outward K+ currents. Journal of Pineal Research 38(1): 53-61
Wood, L.; Leese, M.P.; Mouzakiti, A.; Purohit, A.; Potter, B.V.L.; Reed, M.J.; Packham, G. 2004: 2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases. Apoptosis: An International Journal on Programmed Cell Death 9(3): 323-332
Girot, P.; Averty, E.; Flayeux, I.; Boschetti, E. 2004: 2-Mercapto-5-benzimidazolesulfonic acid: an effective multimodal ligand for the separation of antibodies. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 808(1): 25-33
Van Lomen, G.; Doyon, J.; Coesemans, E.; Boeckx, S.; Cools, M.; Buntinx, M.; Hermans, B.; Van Wauwe, J. 2005: 2-Mercaptoimidazoles, a new class of potent CCR2 antagonists. Bioorganic and Medicinal Chemistry Letters 15(3): 497-500
Pôças, E.Suzana.Carneiro.; Costa, P.Roberto.Ribeiro.; da Silva, A.José.Monteiro.; Noël, Fçois. 2003: 2-Methoxy-3,8,9-trihydroxy coumestan: A new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action. Biochemical Pharmacology 66(11): 2169-2176
Hou, J.; Xiong, H.; Gao, W.; Jiang, H. 2005: 2-Methoxyestradiol at low dose induces differentiation of myeloma cells. Leukemia Research 29(9): 1059-1067
Banerjee, S.N.; Sengupta, K.; Banerjee, S.; Saxena, N.K.; Banerjee, S.K. 2003: 2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells. Neoplasia 5(5): 417-426
Lambert, C.; Apel, K.; Biesalski, H.Konrad.; Frank, J. 2003: 2-methoxyestradiol induces caspase-independent, mitochondria-centered apoptosis in DS-sarcoma cells. International Journal of Cancer 108(4): 493-501
Zhou, N-ning.; Zhu, X-feng.; Zhou, J-ming.; Li, M-zhi.; Zhang, X-shi.; Huang, P.; Jiang, W-qi. 2004: 2-Methoxyestradiol induces cell cycle arrest and apoptosis of nasopharyngeal carcinoma cells. Acta Pharmacologica Sinica 25(11): 1515-1520
Lis, A.; Ciesielski, M.J.; Barone, T.A.; Scott, B.E.; Fenstermaker, R.A.; Plunkett, R.J. 2004: 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro. Cancer Letters 213(1): 57-65
Amant, F.; Lottering, M.Liza.; Joubert, A.; Thaver, V.; Vergote, I.; Lindeque, B.G. 2003: 2-Methoxyestradiol strongly inhibits human uterine sarcomatous cell growth. Gynecologic Oncology 91(2): 299-308
Chilman Blair, K. 2003: 2-Methoxyestradiol. Anticancer agent angiogenesis inhibitor. Drugs of the Future 28(11): 1064-1069
Perez-Cerda, C.; Et-Al 2006: 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: An X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease (vol 58, pg 488, 2005). Pediatric Research 59(1): 162
Sass, Jörn.Oliver.; Forstner, R.; Sperl, W. 2004: 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: Impaired catabolism of isoleucine presenting as neurodegenerative disease. Brain and Development 26(1): 12-14
Palacios, S.; Escalante-Semerena, J.C. 2004: 2-Methylcitrate-dependent activation of the propionate catabolic operon (prpBCDE) of Salmonella enterica by the PrpR protein. Microbiology 150(Pt 11): 3877-3887
Grzywacz, P.; Plum, L.A.; Sicinska, W.; Sicinski, R.R.; Prahl, J.M.; DeLuca, H.F. 2004: 2-Methylene analogs of 1alpha-hydroxy-19-norvitamin D3: synthesis, biological activities and docking to the ligand binding domain of the rat vitamin D receptor. Journal of Steroid Biochemistry and Molecular Biology: 89-90(1-5): 13-17
Zou, C.; Wang, Y.; Shen, Z. 2005: 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. Journal of Biochemical and Biophysical Methods 64(3): 207-215
Noel, K.Dale.; Box, J.M.; Bonne, V.J. 2004: 2-O-Methylation of fucosyl residues of a rhizobial lipopolysaccharide is increased in response to host exudate and is eliminated in a symbiotically defective mutant. Applied and environmental microbiology 70(3): 1537-1544
Yeh, J-Hsien.; Huang, C-Jen.; Lee, J-Hwa.; Hsu, S-Shong.; Chen, J-Shyr.; Cheng, H-Hsiung.; Chang, H-Tai.; Huang, J-Khing.; Chung, H-Min.; Mei-Yin, Y.; Jan, C-Ren. 2005: 2-O-methyl PAF as a Ca2+ mobilizer in Madin Darby canine kidney cells. Life Sciences 77(3): 336-344
Hibasami, H.; Saitoh, K.; Katsuzaki, H.; Imai, K.; Aratanechemuge, Y.; Komiya, T. 2004: 2-O-methylisohemigossylic acid lactone, a sesquiterpene, isolated from roots of mokumen (Gossampinus malabarica) induces cell death and morphological change indicative of apoptotic chromatin condensation in human promyelotic leukemia HL-60 cells. International Journal of Molecular Medicine 14(6): 1029-1033
Teepker, M.; Anthes, N.; Krieg, Jürgen-Christian.; Vedder, H. 2003: 2-OH-estradiol, an endogenous hormone with neuroprotective functions. Journal of Psychiatric Research 37(6): 517-523
Oikawa, M.; Takeda, Y.; Sasaki, M. 2005: 2-Oxo-1,2-ethylenedioxy group as a linker for solution-, liquid-, and solid-phase syntheses to discover drug-like small molecules. Tetrahedron Letters 46(27): 4667-4670
Baslow, M.H.; Dyakin, V.V.; Nowak, K.L.; Hungund, B.L.; Guilfoyle, D.N. 2005: 2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice: evidence of a link between neuron NAAG release and hyperemia. Journal of Molecular Neuroscience: Mn 26(1): 1-15
de Witte, N.V.; Stoppani, Aés.O.M.; Dubin, M. 2004: 2-Phenyl-beta-lapachone can affect mitochondrial function by redox cycling mediated oxidation. Archives of Biochemistry and Biophysics 432(2): 129-135
Kitanaka, J.; Kitanaka, N.; Tatsuta, T.; Takemura, M. 2005: 2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice. Pharmacology Biochemistry and Behavior 82(3): 488-494
Walter, G.; Liebl, R.; von Angerer, E. 2004: 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 88(4-5): 409-420
Luszczki, J.J.; Mohamed, M.; Czuczwar, S.J. 2006: 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice. European Journal of Pharmacology 531(1-3): 66-73
He, Y.; Wu, B.; Yang, J.; Robinson, D.; Risen, L.; Ranken, R.; Blyn, L.; Sheng, S.; Swayze, E.E. 2003: 2-Piperidin-4-yl-benzimidazoles with broad spectrum antibacterial activities. Bioorganic and Medicinal Chemistry Letters 13(19): 3253-3256
Goto, M.; Ogawa, H.; Isobe, T.; Kawasaki, M.; Kometani, T. 2003: 2-Propanol treatment of Candida rugosa lipase and its hydrolytic activity. Journal of Molecular Catalysis B Enzymatic 24-25: 67-73, 1 October
Kasiotis, K.M.; Haroutounian, S.A. 2005: 2-Pyridin-2-yl-1H-indole derivatives: synthesis, estrogen receptor binding affinity, and photophysical properties. Bioorganic Chemistry 34(1): 1-14
Kawahara, S-ichi.; Uchimaru, T.; Taira, K. 2003: 2-Pyridone and 3-oxo-1,2,6-thiadiazine-1,1-dioxide derivatives: A new class of hydrogen bond equivalents of uracil. Journal of Computer-Aided Molecular Design 17(5-6): 329-334
Subach, O.M.; Khoroshaev, A.V.; Gerasimov, D.N.; Baskunov, V.B.; Shchyolkina, A.K.; Gromova, E.S. 2004: 2-Pyrimidinone as a probe for studying the EcoRII DNA methyltransferase-substrate interaction. European Journal of Biochemistry 271(12): 2391-2399
Fairlamb, I.J.S.; Marrison, L.R.; Dickinson, J.M.; Lu, F-Ju.; Schmidt, J.Peter. 2004: 2-pyrones possessing antimicrobial and cytotoxic activities. Bioorganic and Medicinal Chemistry 12(15): 4285-4299
Scapecchi, S.; Martelli, C.; Ghelardini, C.; Guandalini, L.; Martini, E.; Gualtieri, F. 2003: 2-Pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs. Farmaco 58(9): 715-722
Castex, Cédric.; Merida, P.; Blanc, E.; Clair, P.; Rees, A.R.; Temsamani, J. 2004: 2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance. Anti-Cancer Drugs 15(6): 609-617
Gao, Z-Guo.; Mamedova, L.K.; Chen, P.; Jacobson, K.A. 2004: 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors. Biochemical Pharmacology 68(10): 1985-1993
Kobori, A.; Murase, T.; Suda, H.; Saito, I.; Nakatani, K. 2004: 2-Ureidoquinoline: a useful molecular element for stabilizing single cytosine and thymine bulges. Bioorganic and Medicinal Chemistry Letters 14(13): 3431-3433
Wai, K.M.; Tanner, P.A.; Tam, C.W.F. 2005: 2-Year study of chemical composition of bulk deposition in a south China coastal city: Comparison with east Asian cities. Environmental Science and Technology 39(17): 6542-6547
Wu, J.; Qi, D.; Wei, K.; Li, J.; Chen, X.; Wang, A.; Liu, W.; Xue, Q.; Qiao, L. 2005: 2-[(3-carboxy-1-oxoprogy1) amino]-2-deoxy-D-glucose induces apoptosis in Hep G2 cells. Experimental Oncology 27(1): 52-55
Enguehard-Gueiffier, Cécile.; Hübner, H.; El Hakmaoui, A.; Allouchi, H.; Gmeiner, P.; Argiolas, A.; Melis, M.Rosaria.; Gueiffier, A. 2006: 2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist. Journal of Medicinal Chemistry 49(13): 3938-3947
Drakulić, B.J.; Juranić, Z.D.; Stanojković, T.P.; Juranić, I.O. 2005: 2-[(Carboxymethyl)sulfanyl]-4-oxo-4-arylbutanoic acids selectively suppressed proliferation of neoplastic human HeLa cells. A SAR/QSAR study. Journal of Medicinal Chemistry 48(17): 5600-5603
Nakane, M.; Cowart, M.D.; Hsieh, G.C.; Miller, L.; Uchic, M.E.; Chang, R.; Terranova, M.A.; Donnelly-Roberts, D.L.; Namovic, M.T.; Miller, T.R.; Wetter, J.M.; Marsh, K.; Stewart, A.O.; Brioni, J.D.; Moreland, R.B. 2005: 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist. Neuropharmacology 49(1): 112-121
Seefeldt, T.; Dwivedi, C.; Peitz, G.; Herman, J.; Carlson, L.; Zhang, Z.; Guan, X. 2005: 2-Acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylcarbonylamino)- phenylcarbamoylsulfanyl]propionic acid and its derivatives as a novel class of glutathione reductase inhibitors. Journal of Medicinal Chemistry 48(16): 5224-5231
Paku, Sándor.; Nagy, P.; Kopper, László.; Thorgeirsson, S.S. 2004: 2-acetylaminofluorene dose-dependent differentiation of rat oval cells into hepatocytes: confocal and electron microscopic studies. Hepatology 39(5): 1353-1361
Diao-Hui-Ling; Zhou-Chun-Xian; Yu-Yan-Ke; Yang-Jun 2006: 2-acetylaminofluorene induces gamma H2AX foci formation in CHL cells. Zhongguo Yaolixue Yu Dulixue Zazhi 20(2): 131-137
Manaka, A.; Ishii, T.; Takahashi, K.; Sato, M. 2005: 2-acylimino-3-alkyl-3H-thiazoline derivatives: one-pot, three-component condensation synthesis of novel beta-turn mimics. Tetrahedron Letters 46(3): 419-422
Liberatore, A-Marie.; Schulz, J.; Pommier, J.; Barthelemy, M-Anne.; Huchet, M.; Chabrier, P-Etienne.; Bigg, D. 2004: 2-alkyl-4-arylimidazoles: structurally novel sodium channel modulators. Bioorganic and Medicinal Chemistry Letters 14(13): 3521-3523
Leese, M.P.; Newman, S.P.; Purohit, A.; Reed, M.J.; Potter, B.V.L. 2004: 2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents. Bioorganic and Medicinal Chemistry Letters 14(12): 3135-3138
Nelson, M.E.; Loktionova, N.A.; Pegg, A.E.; Moschel, R.C. 2004: 2-amino-O4-benzylpteridine derivatives: potent inactivators of O6-alkylguanine-DNA alkyltransferase. Journal of Medicinal Chemistry 47(15): 3887-3891
Chung, M-Kyo.; Lee, H.; Mizuno, A.; Suzuki, M.; Caterina, M.J. 2004: 2-aminoethoxydiphenyl borate activates and sensitizes the heat-gated ion channel TRPV3. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 24(22): 5177-5182
Dobrydneva, Y.; Abelt, C.J.; Dovel, B.; Thadigiri, C.M.; Williams, R.L.; Blackmore, P.F. 2005: 2-aminoethoxydiphenyl borate as a prototype drug for a group of structurally related calcium channel blockers in human platelets. Molecular Pharmacology 69(1): 247-256
Wu, J.; Takeo, T.; Suga, S.; Kanno, T.; Osanai, T.; Mikoshiba, K.; Wakui, M. 2004: 2-aminoethoxydiphenyl borate inhibits agonist-induced Ca2+ signals by blocking inositol trisphosphate formation in acutely dissociated mouse pancreatic acinar cells. Pflugers Archiv: European Journal of Physiology 448(6): 592-595
Hu, H-Zhen.; Gu, Q.; Wang, C.; Colton, C.K.; Tang, J.; Kinoshita-Kawada, M.; Lee, L-Yuan.; Wood, J.D.; Zhu, M.X. 2004: 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. Journal of Biological Chemistry 279(34): 35741-35748
Padar, S.; Bose, D.D.; Livesey, J.C.; Thomas, D.W. 2005: 2-Aminoethoxydiphenyl borate perturbs hormone-sensitive calcium stores and blocks store-operated calcium influx pathways independent of cytoskeletal disruption in human A549 lung cancer cells. Biochemical Pharmacology 69(8): 1177-1186
Sugiyama, T.; Fujita, M.; Koide, N.; Mori, I.; Yoshida, T.; Mori, H.; Yokochi, T. 2004: 2-aminopurine inhibits lipopolysaccharide-induced nitric oxide production by preventing IFN-beta production. Microbiology and Immunology 48(12): 957-963
Connolly, S.; Aberg, A.; Arvai, A.; Beaton, H.G.; Cheshire, D.R.; Cook, A.R.; Cooper, S.; Cox, D.; Hamley, P.; Mallinder, P.; Millichip, I.; Nicholls, D.J.; Rosenfeld, R.J.; St-Gallay, S.A.; Tainer, J.; Tinker, A.C.; Wallace, A.V. 2004: 2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution. Journal of Medicinal Chemistry 47(12): 3320-3323
Das, J.; Chen, P.; Norris, D.; Padmanabha, R.; Lin, J.; Moquin, R.V.; Shen, Z.; Cook, L.S.; Doweyko, A.M.; Pitt, S.; Pang, S.; Shen, D.Ren.; Fang, Q.; de Fex, H.F.; McIntyre, K.W.; Shuster, D.J.; Gillooly, K.M.; Behnia, K.; Schieven, G.L.; Wityak, J.; Barrish, J.C. 2006: 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor. Journal of Medicinal Chemistry 49(23): 6819-6832
Zhang, A.; Xiong, W.; Hilbert, J.E.; DeVita, E.K.; Bidlack, J.M.; Neumeyer, J.L. 2004: 2-aminothiazole-derived opioids. Bioisosteric replacement of phenols. Journal of Medicinal Chemistry 47(8): 1886-1888
Argirov, O., K.; Lin, B.; Ortwerth, B., J. 2005: 2-ammonio-6-(3-oxidopyridinium-1-yl)hexanoate (OP-lysine) is a newly identified advanced glycation end product in cataractous and aged human lenses (vol 279, pg 6487, 2004). Journal of Biological Chemistry 280(19): 19436
Stanke-Labesque, Fçoise.; Mallaret, M.; Lefebvre, B.; Hardy, Gëlle.; Caron, Fçoise.; Bessard, G. 2004: 2-Arachidonoyl glycerol induces contraction of isolated rat aorta: role of cyclooxygenase-derived products. Cardiovascular Research 63(1): 155-160
Zhao, Q.; He, Z.; Chen, N.; Cho, Y-Yeon.; Zhu, F.; Lu, C.; Ma, W-Ya.; Bode, A.M.; Dong, Z. 2005: 2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells. Journal of Biological Chemistry 280(29): 26735-26742
Kishimoto, S.; Kobayashi, Y.; Oka, S.; Gokoh, M.; Waku, K.; Sugiura, T. 2004: 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. Journal of Biochemistry 135(4): 517-524
Wagner, J.A.; Abesser, M.; Harvey-White, J.; Ertl, G. 2006: 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. Journal of Cardiovascular Pharmacology 47(5): 650-655
Yan, L.; Budhu, R.; Huo, P.; Lynch, C.L.; Hale, J.J.; Mills, S.G.; Hajdu, R.; Keohane, C.A.; Rosenbach, M.J.; Milligan, J.A.; Shei, G-Ju.; Chrebet, G.; Bergstrom, J.; Card, D.; Mandala, S.M. 2006: 2-aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic and Medicinal Chemistry Letters 16(13): 3564-3568
Vidrio, H.; Medina, M. 2005: 2-bromoethylamine, a suicide inhibitor of semicarbazide-sensitive amine oxidase, increases hydralazine hypotension in rats. Journal of Cardiovascular Pharmacology 46(3): 316-324
Lewis, D.N.; Nyska, A.; Johnson, K.; Malarkey, D.E.; Ward, S.; Streicker, M.; Shabat, S.; Peddada, S.; Nyska, M. 2005: 2-Butoxyethanol female-rat model of hemolysis and disseminated thrombosis: X-ray characterization of osteonecrosis and growth-plate suppression. Toxicologic Pathology 33(2): 272-282
Jabbour, E.; Verstovsek, S.; Giles, F.; Gandhi, V.; Cortes, J.; O'Brien, S.; Plunkett, W.; Garcia-Manero, G.; Jackson, C.Ellen.; Kantarjian, H.; Andreeff, M. 2005: 2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome. Cancer 104(3): 541-546
Nguyen, T.H.; Ong, C.K.; Wong, E.; Leong, C.T.; Panasci, L.; Huynh, H. 2005: 2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) exhibits p53-dependent and -independent antiproliferative activity in human nasopharyngeal carcinoma cells in vitro and in vivo. International Journal of Oncology 27(4): 1131-1140
Huynh, H.; Nguyen, T.Hung.; Panasci, L.; Do, P. 2004: 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways. Cancer 101(12): 2881-2891
Picard, D.; Suslova, E.; Briand, P-André. 2006: 2-color photobleaching experiments reveal distinct intracellular dynamics of two components of the Hsp90 complex. Experimental Cell Research 312(19): 3949-3958
Couch, R.D.; Ganem, N.J.; Zhou, M.; Popov, V.M.; Honda, T.; Veenstra, T.D.; Sporn, M.B.; Anderson, A.C. 2006: 2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid disrupts microtubule polymerization: a possible mechanism contributing to apoptosis. Molecular Pharmacology 69(4): 1158-1165
Haffner, C.D.; McDougald, D.L.; Reister, S.M.; Thompson, B.D.; Conlee, C.; Fang, J.; Bass, J.; Lenhard, J.M.; Croom, D.; Secosky-Chang, M.B.; Tomaszek, T.; McConn, D.; Wells-Knecht, K.; Johnson, P.R. 2005: 2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV. Bioorganic and Medicinal Chemistry Letters 15(23): 5257-5261
Maschek, G.; Savaraj, N.; Priebe, W.; Braunschweiger, P.; Hamilton, K.; Tidmarsh, G.F.; De Young, L.R.; Lampidis, T.J. 2004: 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Research 64(1): 31-34
Tanaka, T.; Kurose, A.; Halicka, H.Dorota.; Traganos, F.; Darzynkiewicz, Z. 2006: 2-deoxy-d-glucose reduces the level of constitutive activation of ATM and phosphorylation of histone H2AX. Cell Cycle 5(8): 878-882
Maus, M.; Torrens, Y.; Gauchy, C.; Bretin, S.; Nairn, A.C.; Glowinski, J.; Premont, J. 2006: 2-Deoxyglucose and NMDA inhibit protein synthesis in neurons and regulate phosphorylation of elongation factor-2 by distinct mechanisms. Journal of Neurochemistry 96(3): 815-824
Pagano, M.A.; Meggio, F.; Ruzzene, M.; Andrzejewska, M.; Kazimierczuk, Z.; Pinna, L.A. 2004: 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2. Biochemical and Biophysical Research Communications 321(4): 1040-1044
Swisher, S.G.; Erasmus, J.; Maish, M.; Correa, A.M.; Macapinlac, H.; Ajani, J.A.; Cox, J.D.; Komaki, R.R.; Hong, D.; Lee, H.K.; Putnam, J.B.; Rice, D.C.; Smythe, W.Roy.; Thai, L.; Vaporciyan, A.A.; Walsh, G.L.; Wu, T-Teh.; Roth, J.A. 2004: 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101(8): 1776-1785
Hurh, Y-Jin.; Chen, Z-Hua.; Na, H-Kyung.; Han, S-Young.; Surh, Y-Joon. 2004: 2-Hydroxyestradiol induces oxidative DNA damage and apoptosis in human mammary epithelial cells. Journal of Toxicology and Environmental Health. Part A 67(23-24): 1939-1953
Kim, J.; Darley, D.; Buckel, W. 2005: 2-Hydroxyisocaproyl-CoA dehydratase and its activator from Clostridium difficile. Febs Journal 272(2): 550-561
Gould, S.; Scott, R.C. 2005: 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 43(10): 1451-1459
den Brok, M.W.J.; van der Schoot, S.C.; Nuijen, B.; Hillebrand, M.J.X.; Beijnen, J.H. 2004: 2-Hydroxypropyl-beta-cyclodextrin extracts 2-phenylphenol from silicone tubing. International Journal of Pharmaceutics 278(2): 303-309
Sener, Göksel.; Kabasakal, L.; Sehirli, O.; Ercan, F.; Gedik, N. 2006: 2-Mercaptoethane sulfonate (MESNA) protects against biliary obstruction-induced oxidative damage in rats. Hepatology Research: the Official Journal of the Japan Society of Hepatology 35(2): 140-146
Pérez-Quintanilla, Dán.; del Hierro, I.; Fajardo, M.; Sierra, I. 2005: 2-Mercaptothiazoline modified mesoporous silica for mercury removal from aqueous media. Journal of Hazardous Materials 134(1-3): 245-256
Mequanint, K.; Sheardown, H. 2005: 2-methacryloyloxyethyl N-butylcarbamate: a new co-monomer for synthesis of polyurethane hydrogels with improved mechanical properties for biomedical applications. Journal of Biomaterials Science. Polymer Edition 16(10): 1303-1318
Takata, H.; Tomizawa, K.; Matsushita, M.; Matsui, H. 2004: 2-methoxyestradiol enhances p53 protein transduction therapy-associated inhibition of the proliferation of oral cancer cells through the suppression of NFkappaB activity. Acta Medica Okayama 58(4): 181-187
Perez-Stable, C. 2005: 2-Methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells. Cancer Letters 231(1): 49-64
Gui, Y.; Zheng, X-Long. 2005: 2-methoxyestradiol induces cell cycle arrest and mitotic cell apoptosis in human vascular smooth muscle cells. Hypertension 47(2): 271-280
Maran, A.; Gorny, G.; Oursler, M.J.; Zhang, M.; Shogren, K.L.; Yaszemski, M.J.; Turner, R.T. 2006: 2-methoxyestradiol inhibits differentiation and is cytotoxic to osteoclasts. Journal of Cellular Biochemistry 99(2): 425-434
Kamath, K.; Okouneva, T.; Larson, G.; Panda, D.; Wilson, L.; Jordan, M.Ann. 2006: 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules. Molecular Cancer Therapeutics 5(9): 2225-2233
Barchiesi, F.; Jackson, E.K.; Fingerle, J.; Gillespie, D.G.; Odermatt, B.; Dubey, R.K. 2006: 2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle. Circulation Research 99(3): 266-274
Carballeira, Néstor.M.; Cruz, H.; Kwong, C.D.; Wan, B.; Franzblau, S. 2004: 2-methoxylated fatty acids in marine sponges: defense mechanism against mycobacteria?. Lipids 39(7): 675-680
Falcon, A.A.; Rios, N.; Aris, J.P. 2005: 2-micron circle plasmids do not reduce yeast life span. Fems Microbiology Letters 250(2): 245-251
Minetti, P.; Tinti, M.Ornella.; Carminati, P.; Castorina, M.; Di Cesare, M.Assunta.; Di Serio, S.; Gallo, G.; Ghirardi, O.; Giorgi, F.; Giorgi, L.; Piersanti, G.; Bartoccini, F.; Tarzia, G. 2005: 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization. Journal of Medicinal Chemistry 48(22): 6887-6896
Barroca, N.; Schmidt, R.R. 2004: 2-nitro thioglycoside donors: versatile precursors of beta-D-glycosides of aminosugars. Organic Letters 6(10): 1551-1554
Ong, Y.Siang.; Yap, K.; Ang, E.S.W.; Tan, K.Chai.; Ng, R.T.H.; Song, I.C. 2004: 2-Octylcynanoacrylate-assisted microvascular anastomosis in a rat model: long-term biomechanical properties and histological changes. Microsurgery 24(4): 304-308
Dodsworth, J.A.; Cady, N.C.; Leigh, J.A. 2005: 2-Oxoglutarate and the PII homologues NifI1 and NifI2 regulate nitrogenase activity in cell extracts of Methanococcus maripaludis. Molecular Microbiology 56(6): 1527-1538
Martins, B.Maria.; Svetlitchnaia, T.; Dobbek, H. 2005: 2-Oxoquinoline 8-monooxygenase oxygenase component: active site modulation by Rieske-[2Fe-2S] center oxidation/reduction. Structure 13(5): 817-824
Ercoli, M.; Mina, L.; Boido, C.Canu.; Boido, V.; Sparatore, F.; Armani, U.; Piana, A. 2004: 2-phenyl-3-(quinolizidin-1-yl)-5-substituted indoles as platelet antiaggregating agents. Farmaco 59(2): 101-109
Elzein, E.; Palle, V.; Wu, Y.; Maa, T.; Zeng, D.; Zablocki, J. 2004: 2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists. Journal of Medicinal Chemistry 47(19): 4766-4773
Lam, P.N.; Greenfield, S.P.; Williot, P. 2005: 2-stage repair in infancy for severe hypospadias with chordee: Long-term results after puberty. Journal of Urology 174(4 Pt 2): 1567-72; Discussion 1572
Hsieh, P-Wen.; Chang, F-Rong.; Chang, C-Hsien.; Cheng, P-Wen.; Chiang, L-Chai.; Zeng, F-Long.; Lin, K-Hsiang.; Wu, Y-Chang. 2004: 2-Substituted benzoxazinone analogues as anti-human coronavirus (anti-HCoV) and ICAM-1 expression inhibition agents. Bioorganic and Medicinal Chemistry Letters 14(18): 4751-4754
Boyer, J.; Bernardes-Genisson, V.; Farines, V.; Souchard, J-Pierre.; Nepveu, F. 2004: 2-substituted-3H-indol-3-one-1-oxides: Preparation and radical trapping properties. Free Radical Research 38(5): 459-471
Baldwin, S.W.; Long, A. 2004: 2-tert-butyl-3-methyl-2,3-dihydroimidazol- 4-one-N-oxide: a new nitrone-based chiral glycine equivalent. Organic Letters 6(10): 1653-1656
Pionnier, E.; Chabanet, C.; Mioche, L.; Taylor, A.J.; Le Quéré, J-Luc.; Salles, C. 2004: 2. In vivo nonvolatile release during eating of a model cheese: relationships with oral parameters. Journal of Agricultural and Food Chemistry 52(3): 565-571
Lee, S.; Johnson, D.; Dunbar, K.; Dong, H.; Ge, X.; Kim, Y.C.; Wing, C.; Jayathilaka, N.; Emmanuel, N.; Zhou, C.Q.; Gerber, H.L.; Tseng, C.C.; Wang, S.Ming. 2005: 2.45 GHz radiofrequency fields alter gene expression in cultured human cells. Febs Letters 579(21): 4829-4836
Liu, H-Li.; Zhou, H-Na.; Xing, W-Man.; Zhao, J-Feng.; Li, S-Xing.; Huang, J-Fu.; Bi, R-Chang. 2004: 2.6 A resolution crystal structure of the bacterioferritin from Azotobacter vinelandii. Febs Letters 573(1-3): 93-98
Wallner, K.; Merrick, G.; True, L.; Sherertz, T.; Sutlief, S.; Cavanagh, W.; Butler, W. 2005: 20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: Preliminary biochemical outcomes from a prospective randomized multi-center trial. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 75(3): 307-310
Ruiz-Tovar, J.; Pérez de Oteyza, J.; Collado, M.V.; Rojo, R.; García Villanueva, A. 2006: 20 years experience in the management of Zenker's diverticulum in a third-level hospital. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 98(6): 429-435
Waxman, D.; Gavrilets, S. 2005: 20 questions on adaptive dynamics. Journal of Evolutionary Biology 18(5): 1139-1154
Kukuev, E.I. 2004: 20 years of ichthyofauna research on seamounts of the North Atlantic Ridge and adjacent areas. A review. Archive of Fishery and Marine Research 51(1-3): 215-232
Min, J-Ki.; Kim, J-Ho.; Cho, Y-Lai.; Maeng, Y-Sun.; Lee, S-Jeong.; Pyun, B-Jeong.; Kim, Y-Myeong.; Park, J.Hill.; Kwon, Y-Guen. 2006: 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochemical and Biophysical Research Communications 349(3): 987-994
Laffer, C.L.; Laniado-Schwartzman, M.; Nasjletti, A.; Elijovich, F. 2004: 20-HETE and circulating insulin in essential hypertension with obesity. Hypertension 43(2): 388-392
Kaduce, T.L.; Fang, X.; Harmon, S.D.; Oltman, C.L.; Dellsperger, K.C.; Teesch, L.M.; Gopal, V.Raj.; Falck, J.R.; Campbell, W.B.; Weintraub, N.L.; Spector, A.A. 2003: 20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells. Journal of Biological Chemistry 279(4): 2648-2656
Fang, X.; Faraci, F.M.; Kaduce, T.L.; Harmon, S.; Modrick, M.L.; Hu, S.; Moore, S.A.; Falck, J.R.; Weintraub, N.L.; Spector, A.A. 2006: 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase. American Journal of Physiology. Heart and Circulatory Physiology 291(5): H2301-H2307
Ward, N.C.; Hodgson, J.M.; Puddey, I.B.; Beilin, L.J.; Croft, K.D. 2006: 20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans. Diabetes Research and Clinical Practice 74(2): 197-200
Tost, F.H.W.; Darman, J.; Clemens, S. 2003: 20-MHz ultrasound and its value in imaging of lacrimal plugs. Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 218(1): 14-19
Franssens, V.; Smagghe, G.; Simonet, G.; Claeys, I.; Breugelmans, B.; De Loof, A.; Vanden Broeck, J. 2005: 20-Hydroxyecdysone and juvenile hormone regulate the laminarin-induced nodulation reaction in larvae of the flesh fly, Neobellieria bullata. Developmental and Comparative Immunology 30(9): 735-740
Giessing, M.; Slowinski, T.; Deger, S.; Tuerk, I.; Schönberger, S.; Budde, K.; Loening, S.A. 2003: 20-year experience with elderly donors in living renal transplantation. Transplantation Proceedings 35(8): 2855-2857
Mohamed, E.; Lichstein, E. 2004: 20-year follow-up of a patient with coronary artery spasm. Southern Medical Journal 97(10): 1010-1012
Fisher, P.C.; Montgomery, J.S.; Johnston, W.K.; Wolf, J.Stuart. 2006: 200 consecutive hand assisted laparoscopic donor nephrectomies: evolution of operative technique and outcomes. Journal of Urology 175(4): 1439-1443
Di Bernardo, G.; Del Gaudio, S.; Galderisi, U.; Cipollaro, M. 2004: 2000 Year-old ancient equids: an ancient-DNA lesson from pompeii remains. Journal of Experimental Zoology. Part B Molecular and Developmental Evolution 302(6): 550-556
Emmanuel, S.C.; Phua, H.P.; Cheong, P.Y. 2004: 2001 survey on primary medical care in Singapore. Singapore Medical Journal 45(5): 199-213
Lemos Espinal, J.A.; Smith, H.M.; Chiszar, D. 2003: 2001-2002 anurans, exclusive of Rana, from Durango and Chihuahua, Mexico. Bulletin of the: 92-98
Brown, K.S.; Kard, B.M.; Doss, M.P. 2004: 2002 Oklahoma Termite Survey (Isoptera). Journal of the Kansas Entomological Society 77(1): 1-9
Mcfarlane, G.A. 2003: 2002 Pacific Region State of the Ocean: Report of the Fisheries Oceanography Working Group. Canadian Technical Report of Fisheries and Aquatic Sciences 2484: i-v, 1-65
O'leary, M.P.; Baum, N.H.; Bohnert, W.W.; Blizzard, R.; Bonney, W.W.; Cooper, T.P.; Dineen, M.K.; Gee, W.F.; Gormley, E.Ann.; Ignatoff, J.M.; Nachtsheim, D.A.; Painter, M.Ray.; Thomas, R.; Wei, J.T. 2004: 2003 American Urological Association Gallup Survey: Physician practice patterns, cryosurgery/brachytherapy, male infertility, female urology and insurance/professional liability. Journal of Urology 171(6 Pt 1): 2363-2365
Anonymous 2003: 2003 Asia Pacific Digestive Week, Singapore, Singapore, September 27-30, 2003. Journal of Gastroenterology and Hepatology 18(Suppl): A1-A126
Anonymous 2003: 2003 Balint Orban Memorial Program, San Francisco, CA, USA, September 20-24, 2003. Journal of Periodontology 74(8): 1248-1251
Moyal-Barracco, M.; Lynch, P.J. 2004: 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. Journal of Reproductive Medicine 49(10): 772-777
Anonymous 2004: 2003 Junior Meeting, September 30, 2003. Geologica Belgica 7(1-2): 79-84
Whitworth, J.A. 2003: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension 21(11): 1983-1992
Baker, T. 2004: 2003 medical device recalls and field corrections - Year in review. Journal of Clinical Engineering 29(2): 90-105
Mccarthy, D.A. 2005: 2003 summer upwelling events off Florida's central Atlantic Coast. Florida Scientist 68(1): 56-62
Yee, D.; Fairchild, A.; Keyes, M.; Butler, J.; Dundas, G. 2005: 2003 survey of Canadian radiation oncology residents. International Journal of Radiation Oncology Biology Physics 62(2): 526-534
Anonymous 2005: 2004 Annual Scientific Sessions of the American Heart Association, New Orleans, Louisiana, USA, November 7-10, 2004. American Heart Journal 149(2): 240-253
Anonymous 2004: 2004 Bone Workshops: Frontiers of Skeletal Biology, 10th Workshop on Cell Biology of Bone and Cartilage in Health and Diseases; and What Is New in Bisphosphonates, 7th Workshop on Bisphosphonates - From the Laboratory to the Patient, Davos, Switzerland, March 20-26, 2004. Bone (New York) 34(Suppl 1): S1-S98
Anonymous 2004: 2004 International Workshop on Haploidentical Stem Cell Transplantation, Naples, Italy, July 8-10, 2004. Blood Cells Molecules and Diseases 33(3): 176-205
Lipscomb, J., C.; Mattie, D.; Dodd, D., E. 2005: 2004 Toxicology and Risk Assessment Conferences - Introduction. Journal of Toxicology and Environmental Health Part A 68(11-12): 833-836
Simon, S.L.; Anspaugh, L.R.; Hoffman, F.Owen.; Scholl, A.E.; Stone, M.B.; Thomas, B.A.; Lyon, J.L. 2006: 2004 Update of dosimetry for the Utah Thyroid Cohort Study. Radiation Research 165(2): 208-222
Lopez-Beltran, A.; Scarpelli, M.; Montironi, R.; Kirkali, Z. 2006: 2004 WHO classification of the renal tumors of the adults. European Urology 49(5): 798-805
Melmed, S. 2005: 2004 World Health Organization classification of pituitary tumors: what is new?. Acta Neuropathologica 111(1): 78-79
Martin, L. 2005: 2004 asbestos disease guidelines ignore mass screening abuse. American Journal of Respiratory and Critical Care Medicine 171(6): 665; Author Reply 666-7
Thomas, R. 2005: 2004 medical device recalls and field corrections - Year in review. Journal of Clinical Engineering 30(3): 161-180
Arnolds, E. 2006: 2004, een opmerkelijk jaar voor wasplaten in Drenthe. Coolia 49(1): 4-10
Cook, T.M. 2004: 201 combined spinal-epidurals for anaesthesia using a separate needle technique. European Journal of Anaesthesiology 21(9): 679-683
Moralidis, E.; Spyridonidis, T.; Arsos, G.; Apostolopoulos, D.; Karatzas, N.; Vassilakos, P.; Karakatsanis, K. 2004: 201Tl gated single photon emission computed tomographic myocardial perfusion imaging in the assessment of global and regional left ventricular function. Would it be favoured over equilibrium radionuclide angiography?. Nuclear Medicine Communications 25(7): 665-673
Suzuki, K.; Doi, S.; Yahara, S.; Uyeda, M. 2004: 2070-DTI, a topoisomerase inhibitor produced by Streptomyces sp. strain No. 2070. Journal of Enzyme Inhibition and Medicinal Chemistry 18(6): 497-503